BPH ENERGY LTD - Annual Report 2012

==> picture [197 x 42] intentionally omitted <==

==> picture [157 x 109] intentionally omitted <==

==> picture [157 x 108] intentionally omitted <==

health[n] resources technology[n]

==> picture [157 x 109] intentionally omitted <==

2012 annual report

==> picture [163 x 35] intentionally omitted <==

==> picture [157 x 109] intentionally omitted <==

Contents
Chairman’s Letter	2	Consolidated Statement of
		Changes in Equity	40
Company Focus and
Developments	4	Consolidated Statement of
		Cash Flows	41
Directors’ Report	17
		Notes to the Consolidated
Auditor’s Independence Declaration	29	Financial Statements	42
Corporate Governance Statement	30	Directors’ Declaration	75
Consolidated Statement of		Independent Auditor’s Report	76
Comprehensive Income	38
		Additional Securities
Consolidated Statement of Financial Position	39	Exchange Information	78

health[n] resources technology[n]

==> picture [156 x 109] intentionally omitted <==

Directors

David Breeze – Chairman/Managing Director Greg Gilbert – Non Executive Director Hock Goh – Non Executive Director Deborah Ambrosini – Executive Director and Company Secretary

Scientific Advisors

Professor Peter Klinken Dr Robin Scaife Associate Professor David Liley

==> picture [596 x 596] intentionally omitted <==

Registered Office

14 View Street, North Perth Western Australia 6006

Principal Business Address

14 View Street, North Perth Western Australia 6006 Telephone: (08) 9328 8366 Facsimile: (08) 9328 8733 www.bphenergy.com.au [email protected]

Auditor

Deloitte Touche Tohmatsu Level 14 Woodside Plaza 240 St Georges Terrace, Perth Western Australia 6000

Share Registry

Security Transfer Registrars Pty Ltd 770 Canning Highway, Applecross Western Australia 6153

Australian Securities Exchange Listing Australian Securities Exchange Limited (Home Exchange: Perth, Western Australia) ASX Code: BPH

Australian Business Number

41 095 912 002

bph energy | 2012 annual report

health[n] technology[n] resources

Chairman’s Letter

Dear Shareholder,

The past year has seen BPH Energy continue in the further development of its biotechnology assets.

Cortical Dynamics has now begun its first human clinical trial using the complete BAR monitoring system within the operating room. It is expected that a total of 20 patients undergoing cardiopulmonary bypass surgery will be enrolled in the trial located at St Vincent’s Hospital, Melbourne. The study is designed to detect varying levels of anaesthetic agents in an operating room environment where the presence of multiple sources of artefacts is known to complicate the EEG assessment of anaesthetic action. The study has recruited multiple patients and it is anticipated to be completed later this year.

==> picture [234 x 167] intentionally omitted <==

Cortical Dynamics also had the honour of the BAR monitor being named as a finalist for the health category of The 2011 Australian Innovation Challenge, a national innovation competition supported by the Department of Industry, Innovation, Science, Research and Tertiary Education.

During the period, independent researchers in China found that reduced HLS5 levels were shown to correlate with worse tumour grade, increased tumour size and elevated serum AFP levels, a marker of liver cancer. This new study greatly supports the research by Molecular Discovery Systems and The West Australian Institute of Medical Research on this tumour suppressor gene.

==> picture [268 x 228] intentionally omitted <==

==> picture [178 x 228] intentionally omitted <==

Dr Robin Scaife, Principal Scientist

2 bph energy | 2012 annual report

BPH Investee company, Advent Energy also embarked upon evaluation of its unconventional shale gas potential in EP 386 and RL 1. The results of the initial study indicated significant potential upside in prospective shale gas resources for Advent with estimated unrisked OGIP for EP 386 & RL 1 in the range from 19 TCF to 141 TCF.

Advent also progressed the appraisal of the existing discoveries of Vienta-1 and Waggon Creek-1 in EP 386 in the north west of Australia.

The completion and flow test program of Waggon Creek-1 was prematurely concluded in November 2011 due to the early onset of the northern wet season; however, preliminary field observations showed that during the 6 hour flow, the well flowed gas at a stabilised rate of approximately 1.1 million standard cubic feet of gas per day (MMscf/d) with surface pressure which was still rising slowly at the end of the flow test. Importantly, no water was produced during this short flow test.

Production testing at Vienta-1 in EP 386 was also performed following the well’s re-completion in 2011. Gas flowed at initial rates of approximately 2.1 MMscf/d, though reduced relatively quickly. Subsequent petrophysical review implies a relatively ‘tight’ section and damaged well bore.

Both Waggon Creek-1 and Vienta-1 have been suspended for future potential production and/or further investigative operations in the 2012 dry season. Immediate plans are afoot to conclude the production testing at Waggon Creek-1 with the inclusion of testing of additional perforated intervals.

We thank you for your support and look forward to year of further developments in 2013.

Yours Sincerely,

Mr David Breeze Chairman

bph energy | 2012 annual report

health[n] technology[n] resources

Company Focus and Developments

Molecular Discovery Systems

Novel Anti-Microtubule Cancer Therapeutics

A team of expert cancer cell biology researchers at Molecular Discovery Systems Limited (MDSystems) have used state-of-the-art technology to screen synthetic molecules and natural extracts for new anti-cancer drugs. Using high-content imaging and computational analyses, these drug screening efforts have now yielded several new compounds that potently inhibit cancer cell proliferation.

==> picture [194 x 134] intentionally omitted <==

One of these new anti-proliferative compounds,

discovered by MDSystems cancer cell biology researcher Dr Robin Scaife, has undergone considerable development toward pre-clinical testing of anti-cancer activity. Detailed analyses of chemical analogues of the new drug have yielded a new compound that exhibits nearly 1000 times the biological activity of the initial entity derived by the primary screening process.

The new compound has undergone extensive in-vitro testing and has been shown to have substantial tumour inhibitory activity in preliminary animal testing. This compound is currently being optimised through successive rounds of medicinal chemistry. MDSystems will continue to focus on this novel anti-microtubule drug in preparation for pre-clinical studies.

The inhibition of cell proliferation and induction of cancer cell death is due to the anti-mitotic activity of these new drugs. Anti-mitotic drugs, such as the blockbuster microtubule cancer drug Taxol®, have long been considered to be among the most clinically important cancer drugs discovered to date[[1]] , generating revenue well in excess of one billion USD/yr[[2]] ,[[3]] . More recently, it has been recognised that some of these microtubule drugs also selectively target the tumour vasculature. Since targeting of the tumour vasculature causes rapid tumour shrinkage, a number of new microtubule drugs have been developed in recent years by a range of pharmaceutical companies. In light of encouraging initial clinical results, these new microtubule drugs are currently undergoing extensive testing for anti-cancer activity in humans[[4]] . The microtubule perturbing compounds recently discovered by researchers at MDSystems clearly have the potential to join this class of highly-promising new anti-cancer drugs.

An exceptional opportunity exists for a drug development company to participate in this lead compound development program.

[1] “Taxol has become one of the most valuable cytotoxic chemotherapeutic agents we have in clinical oncology. It has proven effective in ovarian, breast, lung, and head and neck cancer and it has contributed immensely to the quality of life of cancer patients,” (www.medicalnewstoday.com/articles/26471.php)
[2] “In 2000. BMS reported its annual sales of Taxol® was $1.592 billion - equal to excess $4.3 million per day” (www.21cecpharm.com/px)
[3] “A taxane is a type of chemotherapy that stops cell division in order to fight tumors. Sales of taxanes were approximately $2 billion in 2007,” (www.wikinvest.com/stock/Abraxis_BioScience_(ABII)
[4] Read more at Suite101: New Cancer Treatment in FDA Trials, Vascular Disrupting Agents http:// www.suite101.com/content/new-cancer-treatment-in-fda-trials-vascular-disrupting-agentsa279581#ixzz103Z5L4J1

4 bph energy | 2012 annual report

==> picture [68 x 31] intentionally omitted <==

==> picture [398 x 125] intentionally omitted <==

Drug Discovery and High-Content Screening Technology

MDSystems has core expertise in high-content and high-throughput imaging and analysis, providing services for researchers worldwide. The MDSystems owned IN Cell Analyser 1000 (GE Healthcare) is a semiautomated cellular imaging and analysis platform that combines high-resolution imaging and high-content analysis to provide a technology that rapidly detects and quantifies cellular properties much faster than conventional methods. MDSystems has developed and applied a range of high-content analysis protocols to analyse diverse cellular processes such as cell proliferation, cell cycle progression, apoptosis, cytoskeletal changes and dynamics of intracellular organelles.

A recently synthesized collection of novel drug-like molecules is available at MDSystems for High-Content Screening (HCS). High-throughput screening (HTS) of chemical libraries is widely regarded as the most efficient and cost effective approach to finding hits in early drug discovery. In light of the success of HTS in drug discovery, this technology has recently been developed to include high-content imaging and analysis. By providing access to pathways and phenotypic screening, HCS permits identification of modulators of a multitude of intractable molecular and cellular targets.

In light of encouraging results obtained previously using image-based drug screening, MDS has endeavoured to further develop and exploit this technology in an effort to identify new oncology drug candidates. Notably, funding from the Scott Kirkbride Melanoma Research Centre (SKMRC) has permitted MDS to engage more extensively in early-stage oncology drug discovery using novel chemical resources that have been pre-screened based on their chemical structure and pharmaceutical potential. By employing the semi-automated high-throughput imaging platform at MDS, drug candidate molecules were screened for activities relevant to one of the most established oncology targets.

Broadening MDS’ drug discovery capabilities is the collaboration with the Peter MacCallum Cancer Centre (“Peter Mac”), Australia’s only public hospital solely dedicated to cancer. This collaborative research program is aimed at the discovery and development of new cancer drugs that normalise the function of the key tumour suppressor p53. Under the agreement compounds with the desired anti-cancer activity will be identified and developed by combining the advanced drug screening platform at MDS with procedures pioneered by laboratory researchers at Peter Mac.

In addition to the in-house drug discovery efforts, MDSystems is actively seeking high-content screening contracts.

bph energy | 2012 annual report

health[n] technology[n] resources

Company Focus and Developments

HLS5 Technology

MDSystems is working with Professor Peter Klinken and his team at the Western Australian Institute for Medical Research (WAIMR) to develop and validate HLS5 as a novel tumour suppressor gene. A concerted research effort by leading Australian scientists has revealed that HLS5 works through multiple pathways that may target cancer as well as a range of other diseases such as Huntington’s, Parkinson’s and HIV infection.

==> picture [230 x 107] intentionally omitted <==

The team at WAIMR have uncovered a role for HLS5 in leukaemia and breast cancer, and during that process they also noticed that the gene interacts with a number of key proteins involved in one of the known growth pathways associated with melanoma. They have been able to demonstrate that HLS5 associates with proteins that are able to regulate the growth and migration of melanoma cells.

A grant of approximately $600,000 from the National Health and Medical Research Council (NHMRC) was awarded to the HLS5 team. The grant entitled ‘Characterisation of haemopoietic lineage determining genes’, will provide funding until the end of 2012. The research conducted under this grant will continue to look at the role of HLS5 in blood cell development, leukaemia and cancer.

Of particular significance were the findings of an independent study published in Hepatology[1] , which concluded that reduced HLS5 levels were shown to correlate with worse tumour grade, increased tumour size and elevate serum AFP levels, a marker of liver cancer. The results of this study indicate that the loss of HLS5 expression is a critical event in the development and progression of liver cancer. This independent study greatly supports the research by MDSystems and WAIMR on the HLS5 tumour suppressor gene.

MDSystems has an extensive patent portfolio encapsulating the tumour suppressor gene HLS5 both as a potential therapeutic target and also underpinning its involvement in a variety of disease pathways. The patent portfolio surrounding HLS5 is currently going through the various stages of the patent application process in Australia, Europe, Japan and the US. The patent “Tumour Suppressor Factor” has been issued as a patent in the United States of America and Australia. Additionally, the patent entitled ‘Sumoylation control agent and uses thereof’ has been issued in Australia (2006302728).

1 Jia, D, Wei, L, Guo, W, Zha, R, Bao, M, Chen, Z, Ge, C, Zhao, F, Chen, T, Yao, M, Li, J, Wang, H, Gu, J & He, X 2011, Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma, Hepatology, (Accessed at http://onlinelibrary.wiley.com/doi/10.1002/hep.24495/abstract).

6 bph energy | 2012 annual report

Cortical Dynamics

BAR Technology

Cortical Dynamics is working with BPH and the Swinburne University of Technology (SUT) to develop and commercialise a unique depth of anaesthesia monitoring system for use during major surgery. The core technology is based on real time analysis of the patient’s brain electrical activity, electroencephalograph (EEG), using a proprietary algorithm based on a mathematically and physiologically detailed understanding of the brain’s rhythmic electrical activity.

==> picture [222 x 128] intentionally omitted <==

The theory developed by Associate Professor David Liley, who heads the scientific team at Cortical Dynamics, provides for the first time a meaningful way of relating brain electrical activity to the underlying physiological processes that generate it. Using a physiological approach Cortical Dynamics has developed the Brain Anaesthesia Response (BAR) monitor, a monitor designed to better detect the effect of anaesthetic agents on brain activity and assist anaesthetists in keeping patients optimally anaesthetised. Cortical Dynamics is confident that the BAR’s methodology and index will be a more sensitive measure of the state of the brain during anaesthesia than the current alternatives. Moreover, this unique physiological approach may allow the BAR monitor to be applied to markets beyond that of anaesthesia monitoring and may be applied to neuro-diagnostic applications, including the detection of the early onset of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and in development of drugs associated with these conditions.

Funding received from a NHMRC Development Grant has enabled substantial improvements in the performance of the BAR monitor. In particular, it has resulted in the development of a modified sensor layout having improved performance and sensitivity, as well as an upgrade of the data acquisition module to enable a greater resilience to the effects of noise and artefact in a range of clinical monitoring situations.

Using data collected from third party’s hardware, two clinical trials were initially completed to evaluate the BAR algorithm.The first trial was designed to test the sensitivity of a new method in quantifying the effect various levels of nitrous oxide have on measures of anaesthetic depth. The results were published in the peer reviewed international journal Computers in Biology and Medicine . The second trial was designed to evaluate the sensitivity of the BAR methodology to opioids and other intravenous anaesthetic drugs. These trials have provided evidence that the BAR algorithm is more sensitive than competitive monitors in detecting the effects of anaesthetics on brain activity.

In order to corroborate the results of the trial above a second data set, from a similarly constructed trial, was obtained from Professor Michel Struys from the Department of Anaesthesia, Ghent University Hospital Belgium and Professor Tarmo Lipping from the Tampere University in Finland. The analysis of this European data set using the BAR’s methodology unambiguously indicated that the effects of remifentanil (a powerful synthetic opioid) and propofol (a widely used intravenous general anaesthetic agent) on brain electrical activity can be differentiated. These results suggest that analgesia and anaesthesia may be monitored independently using the EEG. The results of this analysis have been presented at the Australian and New Zealand College of Anaesthetists (ANZCA), and also published in the prestigious journal Anesthesiology in 2010.

bph energy | 2012 annual report

health[n] technology[n] resources

Company Focus and Developments

==> picture [212 x 239] intentionally omitted <==

In what has already been a methodical validation process, Cortical Dynamics has now begun its first human clinical trial using the complete BAR monitoring system within the operating room. It is expected that a total of approximately 20 patients undergoing cardiopulmonary bypass surgery will be enrolled in the trial located at St Vincent’s Hospital, Melbourne. The study is designed to detect varying levels of anaesthetic agents in an operating room environment where the presence of multiple sources of artifacts is known to complicate the EEG assessment of anaesthetic action. The study has recruited multiple patients and it is anticipated to be completed later this year. The validation of the BAR monitoring system within the operating room is an important step in the BAR’s clinical development program. The trial has obtained ethics approval from the St Vincent’s hospital Human Research Ethics Committee and is registered on the Australian New Zealand Clinical Registry.

This is the second trial of the BAR monitor system following a 10 person study at Swinburne University in 2011. This earlier study concluded that all the signal gathering and analysing components of the BAR monitor were functioning correctly, which provided the necessary verification for the BAR system to be used in St Vincent’s Hospital clinical trial.

The BAR monitor was named a 2011 finalist for the health category of The Australian Innovation Challenge, a national innovation competition. The Challenge is a multiple category competition that assists some of the nation’s best ideas to commercialisation or adoption. The Challenge was sponsored by The Australian in association with Shell, and supported by the Commonwealth Department of Innovation, Industry, Science and Research. The BAR’s potential was again acknowledged with the successful application of the 2012 Western Australian Innovation Vouchers Program. A program designed to give financial assistance for professional services that will help innovative products become a commercial reality. The grant monies have been used to engage a regulatory consultant to assist in attaining regulatory conformity for BAR monitor.

The strategic focus for Cortical Dynamics is to validate the BAR systems measurement and monitoring of depth of anaesthesia and to complete development of market ready stand alone products and modules that integrate with market leading holistic patient monitoring systems. The company will continue to explore collaborative arrangements such as those with the European researchers to facilitate development and commercialisation of the Company’s technology.

Cortical Dynamics’ has 4 patent families that have matured into National patent applications in Australia, Europe, New Zealand the United States and variously in China and Japan. Cortical has an additional 5th patent application which has entered the PCT application pathway. “Method of monitoring brain function” has been issued as a patent in New Zealand (541615), Australia (2004206763), Japan (4693763) and the United States (10542549). The patent “Brain Function Monitoring and Display System” has been issued in the People’s Republic of China (101528121), New Zealand (573460) and the United States (20100204604). Additionally, the patent “EEG Analysis System” has been issued in New Zealand (573459).

8 bph energy | 2012 annual report

Diagnostic Array Systems

Diagnostic Array Systems (DAS) has created the BacTrak™ System which is a diagnostic test for the detection of respiratory infections (e.g. diagnosis of pneumonia, Tuberculosis (TB) and Legionella disease). This system identifies the cause of disease by testing for multiple bacteria in a single sputum sample quickly, efficiently and more accurately than current techniques. The test has important implications for the clinical management of infectious diseases by identifying the specific bacteria responsible for a disease and suggesting the most effective therapy. Utilisation of the novel test is intended to provide more information, more quickly, than alternative methods. It has the potential to accelerate therapeutic treatment, lead to a reduction in hospitalisations and help reduce the overuse of antibiotics.

Amongst all infectious diseases, respiratory are the most common illnesses in the world. They are highly contagious and are easily spread. The disease causing bacteria can remain in the air where they can easily reach other individuals by inhalation. The number of patients suffering from respiratory infections is increasing, as is the number of deaths caused by these diseases. DAS has completed their research with in-house validation and has been in discussions with third parties to license the technology.

BPH has assisted with funding the development of BacTrak™ which includes a number of key features that underpin its commercial potential. These include:

Rapid simultaneous detection of 16 respiratory pathogens including Tuberculosis (TB), Legionella, and Methycillin Resistant Staphylococcus Aureus (MRSA).
Results within hours rather than days using the current culture gold standard.
Sensitivity and positive confirmation for the 16 pathogens from easily obtained clinical sputum samples.

Direct anticipated benefits from the project development include:

Earlier, pathogen specific treatment;
Shorter length of hospital stay;
Earlier potential isolation of hospital patients; and
Reduction in the over-prescription of broad-spectrum antibiotics.

The core technology underlying this multiplexed screening is progressing through the various stages of the patent application process in Australia, Canada, Europe, Japan and the US.

bph energy | 2012 annual report 9

health[n] technology[n] resources

Company Focus and Developments

==> picture [439 x 307] intentionally omitted <==

Bonaparte Basin - onshore and offshore Hydrocarbon Discoveries.

Advent Energy

Western Australia / Northern Territory – Onshore Bonaparte Basin

Advent Energy Ltd (“Advent”) holds 100% of each of EP 386 and RL 1 in the onshore Bonaparte Basin in northern Australia. The Bonaparte Basin is a hydrocarbon-bearing sedimentary basin straddling the border between the Northern Territory (NT) and Western Australia (WA). Most of the basin is located offshore, covering 250,000 square kilometres, compared to just over 20,000 square kilometres onshore. In addition to the conventional gas the Bonaparte Basin has been identified as a potential shale gas basin.

Advent holds Exploration Permit EP 386 (2,568 square kilometres in area) which is the sole petroleum permit in the Western Australian section of the onshore Bonaparte Basin. Since 1960 twelve wells have been drilled in or near EP 386 and only sixteen in the whole of the onshore basin, with an excellent technical success rate of encountering hydrocarbons.

Waggon Creek-1, drilled in 1995, provided strong evidence of a significant sweet gas-charged stratigraphic trap with fair to good quality sandstone reservoir within the upper Milligans Formation. Drilling of Vienta-1 in 1998 demonstrated numerous gas shows within Enga Sandstone units, with dry gas flowed to surface and visual porosity described in the cuttings. Both Waggon Creek-1 and Vienta-1 were cased and suspended for future production.

During the period, Advent commenced appraisal of the Waggon Creek-1 and Vienta-1 gas discoveries.

10 bph energy | 2012 annual report

==> picture [425 x 298] intentionally omitted <==

Gas flaring during production testing at Advent’s Vienta-1 well in EP 386.

Vienta-1 was recompleted before commencing a short term production test. Zones tested between 1365m-1369m and 1411m-1421m depth yielded gas flows at initial rates of 2.1 million standard cubic feet of gas per day (MMscf/d) and reducing to 0.6 MMscf/d within an hour’s flow.

The shut in and extended build-up pressure monitoring returned strong pressure recovery. Subsequent data analysis and interpretation indicates the presence of multi-layer reservoirs of relatively tight permeability and extremely high skin damage. In addition, the presence of either a closed fault or pinchout edge is interpreted in close proximity to the wellbore which is consistent with the seismic data showing the possible presence of a stratigraphic pinchout play at the lower tested interval. Indications of over-pressure at this level provide for a higher upside potential that could be confirmed through additional high resolution seismic data acquisition.

The completion and flow test program of Waggon Creek-1 was suspended on Friday 4th November 2011 due to the early onset of the wet season. The well was completed with perforations over intervals 384.1-390.1 m and 393.1-395.1 m in the Milligans Formation sandstone reservoirs. Preliminary field observations showed that during the 6 hour flow through a test separator with back pressure of 50 psi, the well flowed gas at a stabilised rate of approximately 1.07 million standard cubic feet of gas per day (MMscf/d) through a 32/64” choke with Flowing Tubing Head Pressure (FTHP) of 153 psi which was still rising slowly at the end of the flow test. No water was produced during the flow test.

bph energy | 2012 annual report

health[n] technology[n] resources

Company Focus and Developments

==> picture [441 x 244] intentionally omitted <==

Gas flowing during production testing at Advent’s Waggon Creek-1 well in EP 386.

The production test at Waggon Creek-1 with downhole gauges is planned to be concluded during the 2012 dry season to obtain reservoir properties and deliverability.

In the NT, Advent holds Retention Licence RL1 (166 square kilometres in area), which covers the Weaber Gas Field which was originally discovered in 1985. Application has been made to renew the Retention Licence for a further five year term.

Advent has advised that the 2C Contingent Resources* for the Weaber Gas Field in RL1 are 11.5 billion cubic feet (Bcf) of natural gas following an independent audit by RISC. Significant upside 3C Contingent Resources of 45.8 Bcf have also been assessed by RISC.

The results are summarised below:

Weaber Field	1C	2C	3C	Mean1
Gas Initially In Place (Bcf)	0.33	13.9	54.1	21.9
Contingent Resources(Bcf)	0.25	11.5	45.8	18.4

1 The mean is the average of the probabilistic resource distribution
Contingent Resources, as defined under the Society of Petroleum Engineers Petroleum Resource Management System (SPE PRMS) guidelines.

The current rapid development of the Kununurra region in northern Western Australia, including the Ord River Irrigation Area phase 2, the township of Kununurra, and numerous regional resource projects provides an exceptional opportunity for Advent to potentially develop its nearby gas resources.

Advent believes the Ord Expansion project will impact positively on EP 386. The initial phase of works is progressing north of Kununurra and adjacent to Advent’s EP 386 permit. The current Ord expansion project, through Government expenditure of over $300M, has brought road infrastructure to within 15 kilometres of Advent’s Vienta-1 gas well in EP 386 and will greatly assist in the development of Advent’s onshore Bonaparte

12 bph energy | 2012 annual report

Basin gas assets. The construction of all-weather sealed roads within the Ord phase two project provides for suitable infrastructure developments to support a commercial development of the field.

These important investments by the Commonwealth and WA governments provide the impetus for Advent to pursue its objective of developing its wholly owned petroleum resources within EP 386 and RL 1. Significantly, these investments will impact markedly on the energy requirements of the Kununurra region which is currently supplied by hydroelectricity from the Lake Argyle hydroelectric facility and diesel power generation.

Advent is in an exceptional position where it remains the operator and 100% owner of the only petroleum permits in the vicinity of this region.

Unconventional Resources Within EP 386 and RL 1

Advent has completed an initial study of shale gas potential in EP 386 and RL 1. The results indicate significant potential upside in prospective shale gas resources for Advent with estimated unrisked OGIP for EP 386 & RL 1 in the range from 19 TCF to 141 TCF. The thickness of the prospective shale gas play varies from 300m to over 1500m.

The prospectivity of the Bonaparte Basin is evident from the known oil and gas fields in both the offshore and onshore portions of the basin. Advent’s onshore EP 386 and RL 1 contain many large structures with conventional reservoir gas discoveries.

Initial study of shale gas potential in EP 386 and RL 1

The current study analysed all wells drilled in the onshore Bonaparte Basin which has thermally mature thick source rock (>500m) with potential large unconventional resources.

The study shows considerable shale gas and tight gas potential.

The study’s key findings are:-

Multiple petroleum targets are present in EP 386 & RL1 :
Proven conventional gas charged sandstone reservoirs in nearshore marine area of the Milligans Formation;
Unconventional gas-condensate shale play in the shallow marine areas of Lower Milligans Formation;
Unconventional tight gas sandstone and limestone reservoirs in the Langfield, Ningbing & Cockatoo groups below the Milligans Formation;
Lower Milligans Formation shale is prospective for shale gas play with considerably large upside potential;
Marine shale with moderate organic richness: TOC of up to 4.3% from samples in wells within or in close proximity of EP 386. Higher TOC could be present in the north east of EP 386;
Source rocks are mature for gas and oil generation: Ro range 0.44-2.42% & Tmax range from 430 to 480;
Limited geochemical data indicates source rocks at depth shallower than c. 1400m are mature for gas/ wet gas and oil generating windows, but over-mature and in the dry gas generating window at depth below 1400m;
The thickness of the prospective shale gas play is varied from 300m to over 1500m. This would provide significant upside in prospective shale gas resources; and
Unrisked OGIP for EP 386 & RL 1 could be in the range from c. 19 TCF to 141 TCF.

bph energy | 2012 annual report 13

health[n] technology[n] resources

Company Focus and Developments

Garimala-1: Elevated Gas Shows over Milligans-Langfield Section

==> picture [307 x 271] intentionally omitted <==

Elevated gas shows over 1700m in shale/ siltstone section. TOC from Lab matched well with computed value from logs and maximum TOC value can be up to 5%(right column).

Example well composite log from Garimala-1 demonstrating elevated gas shows over a considerable shale sequence. Composite well logs from all onshore Bonaparte Basin wells demonstrate similar characteristics.

Clearly, Advent has a considerable potential hydrocarbon resource and is now working toward an appropriate program to fully identify and understand the nature of the unconventional shale gas/condensate play in its 100% owned EP386 and RL1 permits.

PEP 11 Oil and Gas Permit

Advent now holds 85% of Petroleum Exploration Permit PEP 11 – an exploration permit prospective for natural gas located in the Offshore Sydney Basin. This was achieved following the drilling of New Seaclem-1 that concluded in January 2011. The drilling has shown that the early Permian geological sequence is mature for liquid hydrocarbons.

PEP 11 has successfully been renewed for a further five year term that commenced on 13th August 2012. The minimum work commitments for the renewed term are:

==> picture [256 x 130] intentionally omitted <==

----- Start of picture text -----

Year of Term Minimum Work Requirements
of Permit
1 2000 km 2D seismic reprocessing;
Geotechnical studies
2 200 km 2D seismic survey;
Geotechnical studies
3 Geotechnical studies
4 Drill one (1) exploration well
5 500 km [2] 3D seismic survey
----- End of picture text -----

==> picture [184 x 129] intentionally omitted <==

14 bph energy | 2012 annual report

PEP 11 is a significant offshore exploration area with large scale structuring and potentially multi-Trillion cubic feet (Tcf) gas charged Permo-Triassic reservoirs.

The prospectivity of this proven petroleum basin has been enhanced by the confirmation of the presence of apparent ongoing hydrocarbon seeps. Sub-bottom profile data, swath bathymetry, seismic and echosounder data collected by Geoscience Australia along the continental slope / permit margin has demonstrated active erosional features in conjunction with geophysical indications of gas escape.

Advent has previously interpreted significant seismically indicated gas features. Key indicators of hydrocarbon accumulation features have been interpreted following review of the 2004 seismic data, reprocessed in 2010. The seismic features include apparent Hydrocarbon Related Diagenetic Zones (HRDZ), Amplitude Versus Offset (AVO) anomalies and potential flat spots.

Mapped prospects and leads within the Offshore Sydney Basin are generally located less than 50km from Australia’s largest energy market, the Sydney-Wollongong-Newcastle greater metropolitan area. This area has a population of approximately 5,000,000 people. Traditionally, all natural gas used in New South Wales has been piped in from South Australia and the Bass Strait. However, studies by the Australian Bureau of Agricultural and Resource Economics (ABARE) and the Australian Petroleum Production and Exploration Association (APPEA) state that those sources may not be able to meet the demand for gas in the medium to longer term.

Advent has demonstrated considerable gas generation and migration in the Offshore Sydney Basin, with the previously observed mapped prospects and leads remaining highly prospective for gas.

==> picture [440 x 320] intentionally omitted <==

bph energy | 2012 annual report

health[n] technology[n] resources

Company Focus and Developments

==> picture [439 x 372] intentionally omitted <==

Western Australia – Exmouth Sub-Basin (EP325)

Advent Energy Ltd has an 8.3% interest (Permit Operator: Strike Energy Ltd) in a shallow, near shore permit in the Exmouth sub-Basin region of the Carnarvon Basin, which contains the undeveloped Rivoli Gas Field. The Rivoli Gas Field contains approximately 6.8 – 18 PJ of gas. The permit also contains the Rivoli Deep prospect and other leads. The Joint Venture is now planning for 3D seismic coverage of the Rivoli Gas Field and nearby prospects and leads.

==> picture [279 x 225] intentionally omitted <==

16 bph energy | 2012 annual report

Directors’ Report

The directors of BPH Energy Ltd (”BPH Energy” or the “Company”) present their report on the company and its controlled entities for the financial year ended 30 June 2012.

Directors

The names of directors in office at any time during or since the end of the year are:

D L Breeze

G Gilbert H Goh D Ambrosini

Company Secretary

Ms Deborah Ambrosini continues in her role of Company Secretary. She also holds the position of Financial Controller of the Company and has over 11 years experience in Corporate accounting roles.

Principal Activities

The principal activities of the consolidated entity during the financial year were investment biotechnology entities and an oil and gas exploration entity.

Operating Results

The consolidated loss of the economic entity after providing for income tax was $764,478 (2011: loss $267,884).

Dividends

The Directors recommend that no dividend be paid in respect of the current period and no dividends have been paid or declared since the commencement of the period.

Review of Operations

Investment in Oil and Gas Exploration Company

Advent Energy Ltd (“Advent”):

BPH Energy currently holds an interest of 27.4% in unlisted Australian exploration company Advent.

Advent has assembled a range of hydrocarbon permits which contain near term production opportunities with pre-existing infrastructure and exploration upside.

Advent’s assets include EP 386 and RL 1 (100%) in the onshore Bonaparte Basin in the north of Western Australia and Northern Territory, PEP 11 (85%) in the offshore Sydney Basin and EP 325 (8.3%) in the Exmouth Sub-basin of the Carnarvon Basin near Exmouth in WA. Advent’s portfolio of assets has an estimated AUD 156m invested historically on exploration.

Advent is investigating a considerable potential shale gas resource within EP 386 and RL 1. Studies indicate significant potential upside in prospective shale gas resources with estimated unrisked OGIP in the range from 19 Tcf to 141 Tcf.

bph energy | 2012 annual report

health[n] technology[n] resources

Directors’ Report

A mean contingent Resource of 18.4 Bcf for the Weaber Gas Field (RL 1) has recently been assessed, by an independent third party as a component of Advent’s drive to commercialise its 100% owned onshore Bonaparte Basin assets. The current rapid development of the Kununurra region in northern Western Australia, including the Ord Irrigation Expansion Project and numerous resource projects, provides an exceptional opportunity for Advent to potentially develop its nearby gas resources for the benefit of the region along with Advent and its shareholders.

The Sydney Basin is a proven petroleum basin with excellent potential for the discovery of gas and oil. The demonstration of an active hydrocarbon system with seeps reported in the offshore area and sampling indicated the presence of thermogenic hydrocarbon gas; this is considered to occur in basins actively generating hydrocarbons and /or that contain excellent migration pathways. Drilling during the period has shown that the early Permian geological sequence is mature for hydrocarbons. Whilst no hydrocarbons were encountered at prognosed target horizons reservoir quality sandstones of considerable thickness were observed. Invaluable information was obtained from the drilling that will allow Advent to further assess the numerous prospects and leads within PEP 11

Undiscovered prospective recoverable gas resources for structural targets within the PEP 11 offshore permit have been estimated at 6 trillion cubic feet (at the P50 level) or up to 23.5 Tcf on a probabilistic mean calculation. PEP 11 lies adjacent to the most populous region of Australia and the major industrial hub of Newcastle where LNG production facilities are being developed (independently of Advent).

Investment in Biotechnology Companies

BPH Energy’s existing Biotechnology investments include its 3.89% interest in Cortical Dynamics Limited; 51.82% interest in Diagnostic Array Systems Pty Ltd; 20% interest in Molecular Discovery Systems Limited and its interest in the Surface Enhanced Raman Spectroscopy (‘SERS’) project.

Molecular Discovery Systems Limited (‘MDSystems’)

Drug Discovery:

MDSystems is currently utilising the IN Cell Analyser 1000 for in-house screening of new molecules for drug development. The IN Cell Analyser is ideally suited for screening of chemical compounds that modulate complex cellular responses.

MDSystems has also discovered a new anti-microtubule compound. This compound has undergone extensive in-vitro testing and has been shown to have substantial tumour inhibitory activity in preliminary animal testing. This compound is currently being optimised through successive rounds of medicinal chemistry.

MDSystems will continue to focus on this novel anti-microtubule drug, in addition to developing its drug discovery resources and drug candidate pipeline.

18 bph energy | 2012 annual report

HLS5 Project:

MDSystems is working with the Western Australian Institute for Medical Research (‘WAIMR’) to develop and validate HLS5 as a novel tumour suppressor gene. A concerted research effort by leading Australian scientists has revealed that HLS5 works through multiple pathways that may target cancer as well as a range of other diseases such as Huntington’s, Parkinson’s and HIV infection.

MDSystems has developed an extensive patent portfolio and has exclusive rights to the tumour suppressor gene HLS5, both as a potential therapeutic target and also underpinning its involvement in a variety of disease pathways.

The research on HLS5 was further validated by an independent research study, entitled ‘Genome-Wide Copy Number Analyses Identified Novel Cancer Genes in Hepatocellular Carcinoma’ which was published in the prestigious international journal Hepatology.

Cortical Dynamics Limited (‘Cortical Dynamics’):

Cortical Dynamics is working with BPH Energy and the Swinburne University of Technology (‘SUT’) to develop and commercialise a unique depth of anaesthesia monitoring system for use during major surgery. The core technology is based on real time analysis of the patients electroencephalograph (EEG) using a proprietary algorithm based on a mathematically and physiologically detailed understanding of the brain’s rhythmic electrical activity.

The Cortical Dynamics team lead by Associate Professor David Liley has analysed a comprehensive data set obtained from Europe using the Brain Anaesthesia Response (“BAR”) methodology. The detailed results were published in the prestigious peer-reviewed international Journal of Anesthesiology, Liley et al, 2010, Propfol and Remifentanil Differentially Modulate Frontal Electroencephalographic Activity, 113:292-304. With the paper indicating the potential for the BAR methodology to separately monitor hypnotic and analgesic state. At present there is no known EEG monitor based depth of anaesthesia monitoring approach that is able to achieve this.

Diagnostic Array Systems (“DAS”)

DAS is working with BPH Energy and RMIT to develop and commercialise BacTrak™, a diagnostic tool that is designed to enable pathology laboratories and the emergency departments of hospitals to provide patients with fast and accurate identification of disease causing bacteria from a single sputum sample. The test has important implications for the clinical management of infectious diseases by identifying the specific bacteria responsible for a disease. Utilisation of the novel test is intended to provide more information, more quickly, than alternative methods. It has the potential to accelerate therapeutic treatment, lead to a reduction in hospitalisations and help reduce the overuse of antibiotics.

Financial Position

The net assets of the economic entity decreased by $2,104,769 to $48,789,149 at 30 June 2012. This has largely resulted from cash balances decreasing by $1,123,906 as BPH Energy continued to provide financial support to its investee companies MDSystems and Cortical Dynamics Ltd.

bph energy | 2012 annual report 19

health[n] technology[n] resources

Directors’ Report

Significant Changes in State Of Affairs

The major activities throughout the period were:

The Company entered into a selective buyback agreement with MEC Resources Limited (“MEC”). BPH Energy agreed to buy back up to $1.35 million of MEC’s shareholding in the Company. The number of buy-back Shares was determined by dividing the total Consideration by the 5-day volume weighted average closing price of Shares prior to the date of the buy-back;
Independent researchers in China found that reduced HLS5 levels were shown to correlate with worse tumour grade, increased tumour size and elevated serum AFP levels, a marker of liver cancer. The paper indicated that the loss of HLS5 expression is a critical event in liver cancer supporting the research performed by BPH‘s investee MDSystems Limited (“MDS”) and WAIMR. The paper entitled ‘GenomeWide Copy Number Analyses Identified Novel Cancer Genes in Hepatocellular Carcinoma’ which was published in the prestigious international journal Hepatology;
Advent repaid an amount of $1.8M in full and final settlement of its obligations under the secured loan agreement entered into with BPH Energy on 15 June 2010;
Investee company Cortical Dynamics obtained ethics approval from the Human Research Ethics Committee of St Vincent’s Hospital (St Vincent’s), Melbourne. The study commenced in January 2012 and will employ the BAR monitor to detect varying levels of anaesthetic agents in an operating room environment where the presence of multiple artifacts are known to complicate the EEG assessment of anaesthetic action ;
Cortical Dynamics was awarded the accolade of being named as one of the finalists in the health category of The Australian Innovation Challenge, a national innovation competition;
Investee Advent achieved an independently assessed (RISC) mean Contingent Resource for the Weaber Gas Field (RL 1) of 18.4 Bcf following reprocessing of seismic data and review of all available well data from Weaber. The field has been assessed as comprising a 3C upside potential Contingent Resource of 45.8 Bcf;
Investee Advent re-entered Vienta-1 located within EP 386 for the purpose of recompletion and production testing. Production testing on the lower zone of Vienta-1 was performed and the well observed strong pressure recovery. Advent also re-entered Waggon Creek-1 located within EP 386, and 10km from Vienta-1, for the purpose of recompletion and production testing. The well was flowed for 6 hours before operations were suspended for the northern wet season; and
Investee Advent is investigating a considerable potential shale gas resource within EP 386 and RL 1. Studies indicate significant potential upside in prospective shale gas resources with estimated unrisked OGIP in the range from 19 Tcf to 141 Tcf.

After Balance Date Events

There have not been any matters or circumstances that have arisen since the end of the financial year, that have significantly affected, or may significantly affect, the operations of the company, the results of those operations, or the state of affairs of the company in future financial years.

Environmental Issues

The consolidated group’s operations are not regulated by any significant environmental regulation under law of the Commonwealth or of a state or territory.

20 bph energy | 2012 annual report

Future Developments

The entity will continue its investments in energy resource project and to assist its investee companies to commercialise breakthrough biomedical research developed in universities, medical institutes and hospitals.

Information on Directors

D L Breeze

Managing Director and Executive Chairman – Age 58

Shares held – 6,509,811 Unlisted Options held – 1,000,000

David is a Corporate Finance Specialist with extensive experience in the stock broking industry and capital markets. He has been a corporate consultant to Daiwa Securities; was formerly Manager of Corporate Services for Eyres Reed McIntosh and the State Manager and Associate Director for the stock broking firm BNZ North’s.

David has a Bachelor of Economics and a Masters of Business Administration, and is a Fellow of the Financial Services Institute of Australasia, and a Fellow of the Institute of Company Directors of Australia. He has published in the Journal of Securities Institute of Australia and has also acted as Independent Expert under the Corporations Act. He has worked on the structuring, capital raising and public listing of over 70 companies involving in excess of $250M. These capital raisings covered a diverse range of areas including oil and gas, gold, food, manufacturing and technology.

David is Chairman of Grandbridge Limited, a publicly listed investment and advisory company and an Executive Director of MEC Resources Ltd, Advent Energy Ltd and Cortical Dynamics Limited.

G Gilbert

Non executive Director – Age 64

Shares held – 480,769 Unlisted Options held – nil

Greg is a specialist in strategy and planning and works in the health and aged care sector. He has a Masters of Science from Cranfield University in the UK and, in addition, has a Masters of Health Administration from La Trobe University, an MBA from Deakin University, a BA from the University of Queensland, and a Dip.App Sc from the Royal Military College Duntroon.

Greg has an extensive background in merchant banking and banking, having held the position Global Head of Strategy and Finance and Project Director Global Credit Review with the National Australia Bank, as well as having worked in executive roles with Capel Court Investment Bank, CIBC Australia Limited and Bentley and Chau.

Greg has also worked with the National Australia Bank as an Internal Consultant on strategic operational reviews with Mckinsey and Company and Booz Allen and Hamilton consultants.

A former Lieutenant Colonel in the Australian Defence Force, he has extensive senior management experience in strategic planning, financial management, change management and project management as well as merchant banking and corporate advisory experience in mergers and acquisitions and valuations.

bph energy | 2012 annual report

health[n] technology[n] resources

Directors’ Report

H Goh

Non Executive Director – Age 57

Shares held – 480,769 Unlisted Options held – nil

Hock was formerly President of Network and Infrastructure Solutions, a division of Schlumberger Limited, based in London with revenue in excess of US$1.5 billion. He had global responsibility of Schlumberger’s outsourcing services, security, business continuity and networked related business units.

Prior to that, Hock was President of Schlumberger Asia based in Beijing, China where he managed their Asian operations consisting of a broad range of services including oil field services, outsourcing, financial software and smartcards. Hock was responsible for US$800 million in revenue and more than 2,000 employees spread across 17 countries.

In his 25 year career with Schlumberger, Hock held several other field and management responsibilities in the oil and gas industry spanning more than ten countries in Asia, the Middle East and Europe. Hock started as an oil field service engineer in Indonesia in 1980 before moving to Australia where he worked on rigs in Roma, Queensland, Bass Strait in Victoria and the Northwest Shelf, offshore Western Australia.

Hock is also an operating partner with Baird Capital Partners, the U.S. based buyout fund of Baird Private Equity, providing change-of-control and growth capital to middle-market companies. Baird Private Equity has raised and managed $1.7 billion in capital.

Hock is the Chairman of Netgain Systems, a network monitoring software provider. He also serves on the Board of Xaloy Holdings, a US based steel components manufacturer for the plastic industry, as well as an independent director of THISS Technologies Pte Limited, a Singapore based satellite communication provider. He received his B Eng (Hons) in Mechanical Engineering from Monash University, Australia. He also completed an Advanced Management Program at INSEAD/ France in 2004.

Hock is Chairman of ASX listed company MEC Resources Ltd.

D Ambrosini

Executive Director – Age 38

Shares held – nil Unlisted Options held – 1,000,000

Deborah is a chartered accountant with over 11 years’ experience in accounting and business development spanning the biotechnology, mining, IT communications and financial services sectors. She has extensive experience both nationally and internationally in financial and business planning, compliance and taxation.

Deborah is a member of the Institute of Chartered Accountants and was a state finalist in the 2009 Telstra Business Woman Awards. Deborah was also a recipient of the highly regarded 40 under 40 award held by the WA Business News.

Deborah is also a Director of ASX listed MEC Resources Ltd and Grandbridge Limited and unlisted entities Advent Energy Ltd and Cortical Dynamics Limited.

22 bph energy | 2012 annual report

Remuneration Report (Audited)

This report details the nature and amount of remuneration for key management personnel of BPH Energy.

D L Breeze – Executive Chairman and Managing Director

H Goh – Non Executive Director

G Gilbert – Non Executive Director

D Ambrosini – Executive Director and Company Secretary

All the parties have held their current position for the whole of the financial year and since the end of the financial year.

Remuneration Policy

The remuneration policy of BPH Energy Limited has been designed to align director and executive objectives with shareholder and business objectives by providing a fixed remuneration component and offering specific long-term incentives as determined by the board and/or shareholders. The remuneration report as contained in the 2011 financial accounts was adopted at the Company’s 2011 annual general meeting. The board believes the remuneration policy to be appropriate and effective in its ability to attract and retain the best executives and directors to run and manage the economic entity, as well as create goal congruence between directors, executives and shareholders.

The board’s policy for determining the nature and amount of remuneration for board members and senior executives of the economic entity is as follows:

The remuneration policy, setting the terms and conditions for the executive directors and other senior executives, was developed and approved by the board.
All executives receive a base salary (which is based on factors such as length of service and experience), superannuation, fringe benefits and options.
The board reviews executive packages annually by reference to the economic entity’s performance, executive performance and comparable information from industry sectors and other listed companies in similar industries.

The performance of executives is measured against criteria agreed biannually with each executive and is based predominantly on the amount of their workloads and responsibilities for the company. The board may, however, exercise its discretion in relation to approving incentives, bonuses and options, and can recommend changes to recommendations. Any changes must be justified by reference to measurable performance criteria. The policy is designed to attract the highest calibre of executives and reward them for performance that results in long-term growth in shareholder wealth.

Executives are also entitled to participate in the employee share and option arrangements.

The executive directors and executives which receive salaries receive a superannuation guarantee contribution required by the government, which is currently 9%, and do not receive any other retirement benefits.

Shares given to directors and executives are valued as the difference between the market price of those shares and the amount paid by the director or executive. Options are valued using the Black-Scholes methodology.

bph energy | 2012 annual report

health[n] technology[n] resources

Directors’ Report

The board policy is to remunerate non executive directors at market rates for comparable companies for time, commitment and responsibilities. The remuneration committee determines payments to the non executive directors and reviews their remuneration annually, based on market practice, duties and accountability. Independent external advice is sought when required. The maximum aggregate amount of fees that can be paid to non executive directors is subject to approval by shareholders at the Annual General Meeting. Fees for non executive directors are not linked to the performance of the economic entity. However, to align directors’ interests with shareholder interests, the directors are encouraged to hold shares in the company and are able to participate in the employee option plan.

The board does not have a policy in relation to the limiting of risk to directors and executives in relation to the shares and options provided.

Employment contracts of key management personnel

The employment conditions of the managing director, all of the key management personnel are formalised in contracts of employment. The employment contracts stipulate a six month resignation period. The company may terminate an employment contract without cause by providing six months written notice or making payment in lieu of notice, based on the individual’s annual salary component together with a redundancy payment of six months of the individual’s fixed salary component. Termination payments are generally not payable on resignation or dismissal for serious misconduct. In the instance of serious misconduct the company can terminate employment at any time. Any options not exercised before or on the date of termination will not lapse.

The remaining directors are consultants to BPH Energy and each party can terminate their services by written notice.

Details of Remuneration for the year ended 30 June 2012

The remuneration for each key management personnel of the consolidated entity during the year was as follows:

2012

Key Management Person	Cash and fees	Short-term Bonus	Benefits Non-cash benefit	Other	Post-employment Benefits Superannuation
D L Breeze	148,000	-	-	-	-
G Gilbert	25,000	-	-	-	-
H Goh	25,000	-	-	-	-
D Ambrosini	25,000	-	-	-	-

24 bph energy | 2012 annual report

Details of Remuneration for the year ended 30 June 2012 (continued)

2012 (continued)

==> picture [441 x 421] intentionally omitted <==

----- Start of picture text -----

Key Management Long-term Share-based Total Performance Compensation
Person Benefits payment Related Relating to
Options
Other Equity Options $ % %
D L Breeze - - - 148,000 - -
G Gilbert - - - 25,000 - -
H Goh - - - 25,000 - -
D Ambrosini - - - 25,000 - -
2011
Key Management Short-term Benefits Post-employment
Person Benefits
Cash and fees Bonus Non-cash Other Superannuation
benefit
D L Breeze 148,000 - - - -
G Gilbert 25,000 - - - -
H Goh 25,000 - - - -
D Ambrosini 25,000 - - - -
2011 (continued)
Key Management Long-term Share-based Total Performance Compensation
Person Benefits payment Related Relating to
Options
Other Equity Options $ % %
D L Breeze - - - 148,000 - -
G Gilbert - - - 25,000 - -
H Goh - - - 25,000 - -
D Ambrosini - - - 25,000 - -
----- End of picture text -----

bph energy | 2012 annual report 25

health[n] technology[n] resources

Directors’ Report

Company performance, shareholder wealth and director and executive remuneration

The following table shows the gross revenue and the operating result for the last 5 years for the listed entity, as well as the share price at the end of the respective financial years. Analysis of the actual figures shows a decrease in the revenue from the previous year accompanied by an increase in the loss in the current year which can be attributed to BPH Energy no longer receiving the research and development rebate and unrealised losses on derivatives.

==> picture [441 x 21] intentionally omitted <==

----- Start of picture text -----

2008 2009 2010 2011 2012
----- End of picture text -----

Revenue and other income	1,103,422	162,940	339,253	604,748	300,978
Operating loss attributable to
members of the company	(1,614,219)	(2,215,717)	(208,785)	(220,903)	(739,165)
Share price at Year end	$0.046	$0.02	$0.068	$0.03	$0.017
Earningsper shares(cents)	(1.68)	(2.63)	(0.80)	(0.13)	(0.41)

Share based payments:

The following are the share payment arrangement in existence during the year:

Grant Date	Date of Expiry	Fair Value at Grant Date	Exercise Price	Vesting Date
1 June 2008	30 June 2013	$0.0232	$0.294	1/3 on each
				anniversarydate
24 December 2009	31 December 2014	$0.0266	$0.894	Atgrant date

There were no grants of share based payment compensation to directors and senior management during the year.

There are no further service or performance criteria that need to be met in relation to options granted.

There were no options granted exercised or lapsed during the year.

End of remuneration report.

26 bph energy | 2012 annual report

Additional Information

Meetings of Directors

During the financial year, one meeting of directors were held. Attendances by each director during the year were:

	Number eligible	Directors’ Meetings to attend Number attended
D L Breeze	1	1
D Ambrosini	1	1
G Gilbert	1	1
H Goh	1	1

Indemnifying Officers or Auditors

During or since the end of the financial year the company has given an indemnity or entered an agreement to indemnify, or paid or agreed to pay insurance premiums as follows:

The company has paid premiums to insure each of the following directors against liabilities for costs and expenses incurred by them in defending any legal proceedings arising out of their conduct while acting in the capacity of director of the company, other than conduct involving a wilful breach of duty in relation to the company. The amount of the premium was $26,703.

D Breeze
D Ambrosini
G Gilbert
H Goh

The company has not indemnified the current or former auditor of the Company.

Non-audit Services

The board of directors is satisfied that the provision of non-audit services during the year is compatible with the general standard of independence for auditors imposed by the Corporations Act 2001. The directors are satisfied that the services disclosed below did not compromise the external auditor’s independence for the following reasons:

all non-audit services are reviewed and approved by the board prior to commencement to ensure they do not adversely affect the integrity and objectivity of the auditor; and
the nature of the services provided do not compromise the general principles relating to auditor independence in accordance with APES 110: Code of Ethics for Professional Accountants set by the Accounting Professional and Ethical Standards Board.

No fees for non-audit services were paid/payable to the external auditors during the year ended 30 June 2012 (2011: Nil).

bph energy | 2012 annual report

health[n] technology[n] resources

Directors’ Report

Options

At the date of this report, the unissued ordinary shares of BPH Energy Ltd under option are as follows:

Unlisted Options

==> picture [441 x 21] intentionally omitted <==

----- Start of picture text -----

Grant Date Date of Expiry Exercise Price Number Under Option
----- End of picture text -----

	29 April 2008	29 April 2013	*	250,000
	1 June 2008	30 June 2013	$0.294	1,125,000
16	December 2008	16 December 2013	$0.294	500,000
25	September 2009	30 September 2014	$0.594	75,000
24	December 2009	31 December 2014	$0.894	1,500,000
	21 January2011	21 January2016	$0.16	625,000

The exercise price will be the average amount determined by the market price for the 5 days prior to exercise

On the 8 December 2011 10,185,931 listed options expired in accordance with their terms and conditions. During the year ended 30 June 2012, 4,425 (2011: Nil) ordinary shares of BPH Energy Limited were issued on the exercise of options granted under the BPH Energy Limited Listed Options raising $885 (2011: Nil). No amounts are unpaid on any of the shares.

No person entitled to exercise the option had or has any right by virtue of the option to participate in any share issue of any other body corporate.

No shares or interests have been issued during or since the end of the financial year as a result of exercise of an option.

Proceedings on Behalf of Company

No person has applied for leave of Court to bring proceedings on behalf of the company or intervene in any proceedings to which the company is a party for the purpose of taking responsibility on behalf of the company for all or any part of those proceedings. The company was not a party to any such proceedings during the year.

Auditor’s Independence Declaration

The lead auditor’s independence declaration for the year ended 30 June 2012 has been received and can be found on page 29.

The directors’ report is signed in accordance with a resolution of directors made pursuant to S298(2) of the Corporations Act 2001 .

==> picture [127 x 52] intentionally omitted <==

David Breeze

Dated this 30th August 2012

28 bph energy | 2012 annual report

Auditor’s Independence Declaration

==> picture [112 x 21] intentionally omitted <==

The Board of Directors BPH Energy Limited 14 View Street NORTH PERTH WA 6006

Deloitte Touche Tohmatsu ABN 74 490 121 060 Woodside Plaza Level 14 240 St Georges Terrace Perth WA 6000 GPO Box A46 Perth WA 6837 Australia DX: 206 Tel: +61 (0) 8 9365 7000 Fax: +61 (8) 9365 7001 www.deloitte.com.au

30 August 2012

Dear Board Members

BPH Energy Limited

In accordance with section 307C of the Corporations Act 2001 , I am pleased to provide the following declaration of independence to the directors of BPH Energy Limited.

As lead audit partner for the audit of the financial statements of BPH Energy Limited for the financial year ended 30 June 2012, I declare that to the best of my knowledge and belief, there have been no contraventions of:

(i) the auditor independence requirements of the Corporations Act 2001 in relation to the audit; and

(ii) any applicable code of professional conduct in relation to the audit.

Yours sincerely

==> picture [189 x 35] intentionally omitted <==

DELOITTE TOUCHE TOHMATSU

Chris Nicoloff Partner Chartered Accountants

Liability limited by a scheme approved under Professional Standards Legislation. Member of Deloitte Touche Tohmatsu

bph energy | 2012 annual report

health[n] technology[n] resources

Corporate Governance Statement

The Board of Directors of BPH Energy Limited (“BPH Energy” or “the Company”) (“Group”) is responsible for the corporate governance of the economic entity. The Board guides and monitors the business and affairs of the Company on behalf of the shareholders by whom they are elected and to whom they are accountable.

To ensure that the Board is well equipped to discharge its responsibilities, it has established guidelines and accountability as the basis for the administration of corporate governance.

Corporate Governance Disclosures

BPH Energy Limited and the board are committed to achieving and demonstrating the highest standards of corporate governance. The board continues to review the framework and practices to ensure they meet the interests of shareholders. The company and its controlled entities together are referred to as the Group in this statement.

Composition of the Board

The composition of the Board is determined in accordance with the following principles and guidelines:

the Board should comprise a majority or at least 50% of the Board will be independent non executive directors;
the Board should have at least one director with an appropriate range of qualifications and expertise; and
the Board shall meet at regular intervals and follow meeting guidelines set down to ensure all directors are made aware of, and have available all necessary information, to participate in an informed discussion of all agenda items.

When a vacancy exists, through whatever cause, or where it is considered that the Board would benefit from the service of a new director with particular skills, the Board selects a candidate or panel of candidates with the appropriate expertise.

The Board then appoints the most suitable candidate, who must stand for election at the next general meeting of shareholders. The Company does not have a formal Nomination Committee.

Remuneration and Nomination Committees

The Company does not have a formal Remuneration or Nomination Committee. The full Board attends to the matters normally attended to by a Remuneration Committee and a Nomination committee. Remuneration levels are set by the Company in accordance with industry standards to attract suitable qualified and experienced Directors and senior executives.

30 bph energy | 2012 annual report

Audit Committee

The Company does not have a formal Audit Committee. The full Board carried out the functions of an Audit Committee. Due to the status of the Company and the relatively straight forward accounts of the Company anticipated in the financial year, the Directors believe that at the moment there would be no additional benefits obtained by establishing such a committee. The Board follows the Audit Committee Charter, a copy of which is available on request.

Board Responsibilities

As the Board acts on behalf of and is accountable to the shareholders, it seeks to identify the expectations of the shareholders, as well as other regulatory and ethical expectations and obligations. In addition, the Board is responsible for identifying areas of significant business risk and ensuring arrangements are in place to adequately manage those risks. The Board seeks to discharge these responsibilities in a number of ways.

The responsibility for the operation and administration of the economic entity is delegated by the Board to the Managing Director. The Board ensures that the Managing Director is appropriately qualified and experienced to discharge his responsibilities, and has in place procedures to assess the performance for the Company’s officers, employees, contractors and consultants.

The Board is responsible for ensuring that management’s objectives and activities are aligned with the expectations and risks identified by the Board. It has a number of mechanisms in place to ensure this is achieved, including the following:

Board approval of a strategic plan, designed to meet shareholder needs and manage business risk;
Implementation of operating plans and budgets by management and Board monitoring progress against budget;
Procedures to allow directors, in the furtherance of their duties, to seek independent professional advice at the Company’s expense.

Monitoring Of The Board’s Performance

In order to ensure that the Board continues to discharge its responsibilities in an appropriate manner, the performance of all directors is to be reviewed annually by the chairperson. Directors whose performance is unsatisfactory are asked to retire.

bph energy | 2012 annual report 31

health[n] technology[n] resources

Corporate Governance Statement

Best Practice Recommendation

Outlined below are the 8 Essential Corporate Governance Principles as outlined by the ASX and the Corporate Governance Council. The Company has complied with the Corporate Governance Best Practice Recommendations except as identified below.

Action taken and reasons if not adopted

Principle 1: Lay solid foundations for management and oversight

The relationship between the board and senior management is critical to the Group’s long-term success. The directors are responsible to the shareholders for the performance of the Group in both the short and the longer term and seek to balance sometimes competing objectives in the best interests of the Group as a whole. Their focus is to enhance the interests of shareholders and other key stakeholders and to ensure the Group is properly managed.

The responsibilities of the board include:

providing strategic guidance to the Group including contributing to the development of and approving the corporate strategy;
reviewing and approving business plans, and financial plans including major capital expenditure initiatives;
overseeing and monitoring:
organisational performance and the achievement of the Group’s strategic goals and objectives and
progress of major capital expenditures and other significant corporate projects including any acquisitions or divestments
monitoring financial performance including approval of the annual and half-year financial reports;
appointment, performance assessment and, if necessary, removal of the Managing Director;
ratifying the appointment and/or removal and contributing to the performance assessment for the members of the senior management team including the CFO (Deborah Ambrosini) and the Company Secretary;
ensuring there are effective management processes in place and approving major corporate initiatives;
enhancing and protecting the reputation of the organization;
overseeing the operation of the Group’s system for compliance and risk management reporting to shareholders;

Day to day management of the Group’s affairs and the implementation of the corporate strategy and policy initiatives are formally delegated by the board to the Managing Director and senior executives.

32 bph energy | 2012 annual report

Action taken and reasons if not adopted

Principle 2: Structure the board to add value

The board operates in accordance with the broad principles set out in its charter. The charter details the board’s composition and responsibilities.

The board seeks to ensure that :

at any point in time, its membership represents an appropriate balance between directors with experience and knowledge of the Group and directors with an external or fresh perspective; and
the size of the board is conducive to effective discussion and efficient decision-making.

Directors’ independence

The board has adopted specific principles in relation to directors’ independence. These state that when determining independence, a director must be a non executive and the board should consider whether the director:

is a substantial shareholder of the company or an officer of, or otherwise associated directly with, a substantial shareholder of the company;
is or has been employed in an executive capacity by the company or any other Group member within three years before commencing to serve on the board;
within the last three years has been a principal of a material professional adviser or a material consultant to the company or any other Group member, or an employee materially associated with the service provided;
has a material contractual relationship with the company or a controlled entity other than as a director of the Group;
is free from any business or other relationship which could, or could reasonably be perceived to, materially interfere with the director’s independent exercise of their judgement.

Materiality for these purposes is determined on both quantitative and qualitative bases. A transaction of any amount or a relationship is deemed material if knowledge of it may impact the shareholders’ understanding of the director’s performance.

The board assesses independence each year. To enable this process, the directors must provide all information that may be relevant to the assessment.

Board members

Details of the members of the board, their experience, expertise, qualifications, term of office, relationships affecting their independence and their independent status are set out in the directors’ report under the heading ‘’Information on directors’’. At the date of signing the directors’ report, there are two non executive directors and two executive directors, three of whom have no relationships adversely affecting independence and so are deemed independent under the principles set out above.

Mr Breeze has business dealings with the Group as disclosed in note 25 to the financial report. However, these are not of a value or significance that adversely affect the directors’ independence.

bph energy | 2012 annual report 33

health[n] technology[n] resources

Corporate Governance Statement

Action taken and reasons if not adopted

Term of office

The company’s Constitution specifies that all non executive directors must retire from office no later than the third annual general meeting (AGM) following their last election. Where eligible, a director may stand for re-election, subject to the following limitations:

on attaining the age of 72 years a director will retire, by agreement, at the next AGM and will not seek re-election.

Chair and Managing Director

The Chair is responsible for leading the board, ensuring directors are properly briefed in all matters relevant to their role and responsibilities, facilitating board discussions and managing the board’s relationship with the company’s senior executives. In accepting the position, the Chair has acknowledged that it will require a significant time commitment and has confirmed that other positions will not hinder his effective performance in the role of Chair.

The Managing Director is responsible for implementing Group strategies and policies.

The Chairman does not satisfy the Independence test as the role of the Chairman and the Managing Director is exercised by the same person. The board is of the opinion that the Chairman’s role as Chairman of the Board is appropriate given his experience and knowledge of the business.

Committees

The number of meetings of the company’s board of directors and of each board committee held during the year ended 30 June 2012, and the number of meetings attended by each director is disclosed on page 27.

It is the company’s practice to allow its executive directors to accept appointments outside the company. No appointments of this nature were accepted during the year ended 30 June 2012.

The Company is not of a size at the moment that justifies having a separate Nomination Committee. However, matters typically dealt with by such a committee are dealt with by the Board of Directors.

Notices of meetings for the election of directors comply with the ASX Corporate Governance Council’s best practice recommendations.

34 bph energy | 2012 annual report

Action taken and reasons if not adopted

Principle 3: Promote ethical and responsible decision making

The company has developed a statement of values a which has been fully endorsed by the board and applies to all directors and employees. The Statement is regularly reviewed and updated as necessary to ensure it reflects the highest standards of behaviour and professionalism and the practices necessary to maintain confidence in the Group’s integrity and to take into account legal obligations and reasonable expectations of the company’s stakeholders.

The Statement requires that at all times all company personnel act with the utmost integrity, objectivity and in compliance with the letter and the spirit of the law and company policies.

The purchase and sale of company securities by directors and employees is monitored by the Board.

The company is committed to Diversity and Equal Opportunity within its workforce placing particular focus on the level of gender diversity at senior levels of the organisation. The company ensure this is achieved by :

ensuring recruitment and selection practices enable the availability of a diverse candidate pool for appointments at senior levels; and
ensuring remuneration practices are free from gender bias.

At conclusion of the reporting year one of BPH Energy’s 4 directors is female.

Principle 4: Safeguard integrity in financial reporting

Adopted except as follows:-

The Company does not have a separate Audit Committee. The full Board carries out the functions of an Audit Committee. The Board has the authority, within the scope of its responsibilities, to seek any information it requires from any employee or external party.

Due to the status of the Company and the relatively straight forward accounts of the Company, the Directors at the moment can see no additional benefits to be obtained by establishing such a committee.

The Board follows the Audit Committee Charter, a copy of which is available on request.

External auditors

The Board’s policy is to appoint external auditors who clearly demonstrate quality and independence. The performance of the external auditor is reviewed annually and applications for tender of external audit services are requested as deemed appropriate, taking into consideration assessment of performance, existing value and tender costs. Deloitte was appointed as the external auditor in 2010. It is the Corporation Act’s policy to rotate audit engagement partners on listed companies at least every five years. A partner should not be re-assigned to a listed entity audit engagement if this equates to the partner serving in this role for more than 5 out of 7 successive years.

An analysis of fees paid to the external auditors, including a break-down of fees for non-audit services, is provided in the directors’ report and in note 5 to the financial statements. It is the policy of the external auditors to provide an annual declaration of their independence to the Board.

The external auditor will attend the annual general meeting and be available to answer shareholder questions about the conduct of the audit and the preparation and content of the audit report. The Company is not of a size at the moment that justifies having a internal audit division.

bph energy | 2012 annual report

health[n] technology[n] resources

Corporate Governance Statement

Action taken and reasons if not adopted

Principle 5&6: Make timely and balanced disclosures and respect the rights of shareholders Continuous disclosure and shareholder communication

The company has policies and procedures on information disclosure that focus on continuous disclosure of any information concerning the Group that a reasonable person would expect to have a material effect on the price of the company’s securities. These policies and procedures also include the arrangements the company has in place to promote communication with shareholders and encourage effective participation at general meetings.

The Company Secretary has been nominated as the person responsible for communications with the ASX. This role includes responsibility for ensuring compliance with the continuous disclosure requirements in the ASX Listing Rules and overseeing and co-ordinating information disclosure to the ASX, analysts, brokers, shareholders, the media and the public.

All information disclosed to the ASX is posted on the company’s website as soon as it is disclosed to the ASX. When analysts are briefed on aspects of the Group’s operations, the material used in the presentation is released to the ASX and posted on the company’s web site. Procedures have also been established for reviewing whether any price sensitive information has been inadvertently disclosed and, if so, this information is also immediately released to the market.

All shareholders receive a copy of the company’s annual (full or concise) and half-yearly reports. In addition, the company seeks to provide opportunities for shareholders to participate through electronic means. Recent initiatives to facilitate this include making all company announcements, media briefings, details of company meetings, and financial reports available on the company’s website.

Principle 7: Recognise and manage risk

The board and senior executives are responsible for ensuring there are adequate policies in relation to risk management, compliance and internal control systems. In summary, the company policies are designed to ensure strategic, operational, legal, reputational and financial risks are identified, assessed, effectively and efficiently managed and monitored to enable achievement of the Group’s business objectives.

Considerable importance is placed on maintaining a strong control environment. There is an organisation structure with clearly drawn lines of accountability and delegation of authority. The board actively promotes a culture of quality and integrity.

The responsibility for the operation and administration of the economic entity is delegated by the board to the Managing Director. The board ensures that the Managing Director is appropriately qualified and experienced to discharge his responsibilities, and has in place procedures to assess the performance for the Company’s officers, employees, contractors and consultants. The board receives monthly updates as to the effectiveness of the company’s management of material risks that may impede meeting business objectives.

The board is responsible for ensuring that management’s objectives and activities are aligned with the expectations and risks identified by the Board. It has a number of mechanisms in place to ensure this is achieved, including the following:

Board approval of a strategic plan, designed to meet shareholder needs and manage business risk;
Implementation of operating plans and budgets by management and board monitoring progress against budget;
Procedures to allow directors, in the furtherance of their duties, to seek independent professional advice at the Company’s expense.

36 bph energy | 2012 annual report

Action taken and reasons if not adopted

Principle 7: Recognise and manage risk (continued)

Control procedures cover management accounting, financial reporting, project appraisal, IT security, compliance and other risk management issues. The Managing Director is required to ensure that appropriate controls are in place to effectively manage the identified risks. This is monitored by the board on a monthly basis.

The environment

Information on compliance with significant environmental regulations is set out in the directors’ report.

Corporate reporting

The Managing Director and CFO have made the following certifications to the board:

that the company’s financial reports are complete and present a true and fair view, in all material respects, of the financial condition and operational results of the company and Group and are in accordance with relevant accounting standards;
that the above statement is founded on a sound system of risk management and internal compliance and control which implements the policies adopted by the board and that the company’s risk management and internal compliance and control is operating efficiently and effectively in all material respects in relation to financial reporting risks.

Principle 8: Remunerate fairly and responsibly

The Company is not of a size at the moment that justifies having a separate Remuneration Committee. However, matters typically dealt with by such a committee are dealt with by the board.

The board makes specific recommendations on remuneration packages and other terms of employment for executive directors, other senior executives and non executive directors. The board also reviews gender pay equity on an annual basis to ensure equality.

Each member of the senior executive team signs a formal employment contract at the time of their appointment covering a range of matters including their duties, rights, responsibilities and any entitlements on termination. The standard contract refers to a specific formal job description.

Further information on directors’ and executives’ remuneration, including principles used to determine remuneration, is set out in the directors’ report under the heading ‘’Remuneration report’’. In accordance with Group policy, participants in equity-based remuneration plans are not permitted to enter into any transactions that would limit the economic risk of options or other unvested entitlements.

The board with the Managing Director also assumes responsibility for overseeing management succession planning, including the implementation of appropriate executive development programmes and ensuring adequate arrangements are in place, so that appropriate candidates are recruited for later promotion to senior positions.

bph energy | 2012 annual report 37

health[n] technology[n] resources

Consolidated Statement of Comprehensive Income

for the year ended 30 June 2012

Note Revenue from ordinary activities 2 Other income 2 Other gains and losses 2 Share of associates profit/(loss) Administration expenses Advertising and Promotion expenses Consulting and Legal expenses Research and Development expenses Depreciation and amortisation expense 3 Employee expense Insurance expenses Service Fees Travelling expenses Other expenses Operating Loss Before Income Tax Income tax (expense) /benefit 14 Operating Loss for the Period Other Comprehensive Income Net Gains on available-for-sale financial assets Income tax relating to components of other comprehensive income Total Other Comprehensive income Total Comprehensive Income for the period Operating loss attributable to non-controlling interests Operating Loss attributable to members of the parent entity Total Comprehensive income attributable to owners of the Company Total Comprehensive income attributable to non-controlling interests Earnings Per Share – Basic and diluted earnings per share (cents per share) 6	Consolidated 2012 $ 2011 $
	186,878 352,123 114,100 252,625 (131,732) - (298,038) (1,167,268) (178,537) (558,198) (1,824) (26,167) (185,325) (409,801) (32,937) (45,293) (789) (1,673) (335,128) (315,135) (30,209) (26,377) (131,040) (131,040) - (4,903) (17,790) (12,376)
	(1,042,371) (2,093,483) 277,893 1,825,599
	(764,478) (267,884) - 21,450,000 - (6,435,000)
	- 15,015,000
	(764,478) 14,747,116
	(25,313) (46,981)
	(739,165) (220,903)
	(739,165) 14,794,097 (25,313) (46,981)
	(0.41) (0.13)

38 bph energy | 2012 annual report

Consolidated Statement of Financial Position

as at 30 June 2012

Note Current Assets Cash and cash equivalents 7 Trade and other receivables 8 Financial Assets 10 Other current assets 9 Total Current Assets Non-Current Assets Financial assets Investments in associates 10 13 Intangible assets 11 Property, plant & equipment 12 Total Non-Current Assets Total Assets Current Liabilities Trade and other payables 15 Financial liabilities 16 Provisions 17 Total Current Liabilities Non-Current Liabilities Deferred Tax liabilities 29 Total Non-Current Liabilities Total Liabilities Net Assets Equity Issued capital 18 Reserve 19 Accumulated losses Non-controlling interest Total Equity	Consolidated 2012 $ 2011 $
	1,798,924 2,922,830 2,913 2,857 1,707,203 2,720,363 18,189 8,778
	3,527,229 5,654,828
	338,373 50,253,484 48,949 50,551,521 72,454 72,454 1,271 2,060
	50,665,582 50,674,984
	54,192,811 56,329,812
	572,580 382,479 479,502 434,853 20,072 9,161
	1,072,154 826,493
	4,331,508 4,609,401
	4,331,508 4,609,401
	5,403,662 5,435,894
	48,789,149 50,893,918
	41,511,195 42,860,310 15,431,590 15,422,766 (8,074,395) (7,335,230) (79,241) (53,928)
	48,789,149 50,893,918

The accompanying notes form part of these financial statements.

bph energy | 2012 annual report 39

health[n] technology[n] resources

Consolidated Statement of Changes in Equity

for the year ended 30 June 2012

Note Balance at 1 July 2010 Loss attributable to members of consolidated entity Other Comprehensive income (net of tax) Total Comprehensive income for the year Transactions with owners in their capacity as owners Entitlement issue Shares issued during the financial year 18 Placement Shares – recompliance 18 Capital Raising Costs 18 Employee options expense 19 Balance at 30 June 2011 Balance at 1 July 2011 Loss attributable to members of consolidated entity Other Comprehensive income (net of tax) Total Comprehensive income for the year Transactions with owners in their capacity as owners Shares cancelled in selective buyback 18 Shares issued on exercise of options 18 Employee options expense 19 Balance at 30 June 2012	Consolidated
	Ordinary Share Capital $ Accumu- lated losses $ Option Reserve $ Fair value Adjust- ment $ Total attributable to owners of the parent entity $ Non- controlling Interest $ Total $
	22,427,420 (7,114,327) 391,056 - 15,704,149 (6,947) 15,697,202 - (220,903) - - (220,903) (46,981) (267,884) - - - 15,015,000 15,015,000 - 15,015,000
	- (220,903) - 15,015,000 14,794,097 (46,981) 14,747,116 8,237,507 - - - 8,237,507 - 8,237,507 1,568,333 - - - 1,568,333 - 1,568,333 11,514,920 - - - 11,514,920 - 11,514,920 (887,870) - - - (887,870) - (887,870) - - 16,710 - 16,710 - 16,710
	42,860,310 (7,335,230) 407,766 15,015,000 50,947,846 (53,928) 50,893,918
	42,860,310 (7,335,230) 407,766 15,015,000 50,947,846 (53,928) 50,893,918 - (739,165) - - (739,165) (25,313) (764,478) - - - - - - -
	- (739,165) - - (739,165) (25,313) (764,478) (1,350,000) - - - (1,350,000) - (1,350,000) 885 - - - 885 - 885 - - 8,824 - 8,824 - 8,824
	41,511,195 (8,074,395) 416,590 15,015,000 48,868,390 (79,241) 48,789,149

The accompanying notes form part of these financial statements.

40 bph energy | 2012 annual report

Consolidated Statement of Cash Flows

for the year ended 30 June 2012

Note Cash Flows From Operating Activities Receipts from customers Grant income Payments to suppliers and employees Interest received Net cash used in operating activities 21 Cash Flows From Investing Activities Amounts (to)/from other entities Payment for investments Payment for property, plant and equipment Net cash provided by/used in investing activities Cash Flows From Financing Activities Proceeds from capital raising (net of capital raising costs) Payment for share buyback Net cash provided by/used financing activities Net increase (decrease) in Cash Held Cash At the Beginning Of The Financial Year Cash At The End Of The Financial Year 7	Consolidated 2012 $ 2011 $
	- - - 217,359 (620,224) (1,707,258) 122,485 167,248
	(497,739) (1,322,651)
	722,948 (4,575,108) - (12,000,000) - (1,541)
	722,948 (16,576,649)
	885 18,966,310 (1,350,000) -
	(1,349,115) 18,966,310
	(1,123,906) 1,067,010 2,922,830 1,855,820
	1,798,924 2,922,830

The accompanying notes form part of these financial statements.

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

1. Statement of Significant Accounting Policies

Corporate Information

The financial report includes the consolidated financial statements and the notes of BPH Energy Limited and controlled entities (‘Consolidated Group’ or ‘Group’).

BPH Energy Limited is a company incorporated and domiciled in Australia and listed on the Australian Securities Exchange.

The financial report was authorised for issue on 30th August 2012 by the board of directors.

Basis of Preparation

The financial report is a general purpose financial report that has been prepared in accordance with Australian Accounting Standards, Australian Accounting Interpretations, other authoritative pronouncements of the Australian Accounting Standards Board (“AASB”)and the Corporations Act 2001 .

Australian Accounting Standards set out accounting policies that the AASB has concluded would result in a financial report containing relevant and reliable information about transactions, events and conditions to which they apply. Compliance with Australian Accounting Standards ensures that the financial statements and notes also comply with International Financial Reporting Standards. Material accounting policies adopted in the preparation of this financial report are presented below. They have been consistently applied unless otherwise stated.

The financial report has been prepared on an accruals basis and is based on historical costs, modified, where stated below.

Compliance with IFRS

The consolidated financial statements of the BPH Energy Limited group comply with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB).

Going Concern

The consolidated entity has incurred losses for the year ended 30 June 2012 of $764,478 (2011:losses of $267,884) and has a net cash outflow from operating activities of $497,739 (2011: $1,322,651).

The directors have reviewed their expenditure and their commitments for the consolidated entity. The directors as a part of their cash monitoring, may voluntarily suspended cash payments for their director’s fees to conserve cash.

The directors have prepared cash flow forecasts that indicate that the consolidated entity will have sufficient cash flows for a period of at least 12 months from the date of this report.

Based on the cash flow forecasts and the monitoring of operational costs, the directors are satisfied that, the going concern basis of preparation is appropriate. The financial report has therefore been prepared on a going concern basis, which assumes continuity of normal business activities and the realisation of assets and the settlement of liabilities in the ordinary course of business.

42 bph energy | 2012 annual report

1. Statement of Significant Accounting Policies (continued)

Accounting Policies

(a) Principles of Consolidation

A controlled entity is any entity BPH Energy Limited has the power to control the financial and operating policies of so as to obtain benefits from its activities.

A list of controlled entities is contained in Note 20 to the financial statements. All controlled entities have a June financial year-end.

As at reporting date, the assets and liabilities of all controlled entities have been incorporated into the consolidated financial statements as well as their results for the year then ended.

The results of subsidiaries acquired or disposed of during the year are included in the consolidated statement of comprehensive income from the effective date of acquisition and up to the effective date of disposal, as appropriate.

All inter-company balances and transactions between entities in the economic entity, including any unrealised profits or losses, have been eliminated on consolidation. Accounting policies of subsidiaries have been changed where necessary to ensure consistencies with those policies applied by the parent entity.

Non-controlling interests in the results and equity of subsidiaries are shown separately in the statement of comprehensive income, statement of changes in equity and statement of financial position respectively.

Changes in the Group’s interests in subsidiaries that do not result in a loss of control are accounted for as equity transactions. The carrying amounts of the Group’s interests and the non-controlling interests are adjusted to reflect the changes in their relative interests in the subsidiaries. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognised directly in equity and attributed to owners of the Company.

When the Group loses control of a subsidiary, the profit or loss on disposal is calculated as the difference between (i) the aggregate of the fair value of the consideration received and the fair value of any retained interest and (ii) the previous carrying amount of the assets (including goodwill), and liabilities of the subsidiary and any non-controlling interests. Amounts previously recognised in other comprehensive income in relation to the subsidiary are accounted for (i.e. reclassified to profit or loss or transferred directly to retained earnings) in the same manner as would be required if the relevant assets or liabilities were disposed of. The fair value of any investment retained in the former subsidiary at the date when control is lost is regarded as the fair value on initial recognition for subsequent accounting under AASB 139 Financial Instruments: Recognition and Measurement or, when applicable, the cost on initial recognition of an investment in an associate or jointly controlled entity.

(b) Income Tax

The charge for current income tax expense is based on the profit for the year adjusted for any nonassessable or disallowed items. It is calculated using the tax rates that have been enacted or are substantially enacted by the statement of financial position date.

bph energy | 2012 annual report 43

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(b) Income Tax (continued)

Deferred tax is accounted for using the statement of financial position liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. No deferred income tax will be recognised from the initial recognition of an asset or liability, excluding a business combination, where there is no effect on accounting or taxable profit or loss.

Deferred tax is calculated at the tax rates that are expected to apply to the period when the asset is realised or liability is settled. Deferred tax is recognised in the statement of comprehensive income except where it relates to items that may be recognised directly to equity, in which case the deferred tax is adjusted directly against equity.

Deferred income tax assets are recognised to the extent that it is probable that future tax profits will be available against which deductible temporary differences or unused tax losses and tax credits can be utilised.

The amount of benefits brought to account or which may be realised in the future is based on the assumption that no adverse change will occur in income taxation legislation and the anticipation that the economic entity will derive sufficient future assessable income to enable the benefit to be realised and comply with the conditions of deductibility imposed by the law.

BPH Energy Limited and its wholly-owned Australian subsidiaries have formed an income tax consolidated group under the tax consolidation regime. The group notified the Australian Taxation Office on 30 June 2006 that it had formed an income tax consolidated group to apply from 30 June 2006. The tax consolidated group has entered a tax funding agreement whereby each company in the group contributes to the income tax payable in proportion to their contribution to the net profit before tax of the tax consolidated group.

(c) Property, Plant & Equipment

Each class of property, plant and equipment is carried at cost less, where applicable, any accumulated depreciation and impairment losses.

Plant and equipment

Plant and equipment are measured on the cost basis.

The carrying amount of plant and equipment is reviewed annually by directors to ensure it is not in excess of the recoverable amount from these assets. The recoverable amount is assessed on the basis of the expected net cash flows that will be received from the assets employment and subsequent disposal. The expected net cash flows have been discounted to their present values in determining recoverable amounts.

The cost of fixed assets constructed within the economic entity includes the cost of materials, direct labour, borrowing costs and an appropriate proportion of fixed and variable overheads.

Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the income statement during the financial period in which they are incurred.

44 bph energy | 2012 annual report

1. Statement of Significant Accounting Policies (continued)

(c) Property, Plant & Equipment (continued)

Depreciation

The depreciable amount of all fixed assets including building and capitalised lease assets, but excluding freehold land, is depreciated on a straight-line basis over their useful lives to the economic entity commencing from the time the asset is held ready for use. Leasehold improvements are depreciated over the shorter of either the unexpired period of the lease or the estimated useful lives of the improvements.

The depreciation rates used for each class of depreciable assets are:

Class of Fixed Asset Depreciation Rate Computers 33 % Office furniture 15 %

The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each statement of financial position date.

An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount.

Gains and losses on disposals are determined by comparing proceeds with the carrying amount. These gains and losses are included in the income statement. When revalued assets are sold, amounts included in the revaluation reserve relating to that asset are transferred to retained earnings.

(d) Leases

Leases of fixed assets where substantially all the risks and benefits incidental to the ownership of the asset, but not the legal ownership that are transferred to entities in the economic entity are classified as finance leases.

Finance leases are capitalised by recording an asset and a liability at the lower of the amounts equal to the fair value of the leased property or the present value of the minimum lease payments, including any guaranteed residual values. Lease payments are allocated between the reduction of the lease liability and the lease interest expense for the period.

Leased assets are depreciated on a straight-line basis over the shorter of their estimated useful lives or the period of the lease.

Lease payments for operating leases, where substantially all the risks and benefits remain with the lessor, are charged as an expense on a straight line basis over the lease term.

Lease incentives under operating leases are recognised as a liability and amortised on a straight-line basis over the life of the lease term.

bph energy | 2012 annual report 45

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(e) Financial Instruments

Recognition and Initial Measurement

Financial instruments, incorporating financial assets and financial liabilities, are recognised when the entity becomes a party to the contractual provisions of the instrument. Trade date accounting is adopted for financial assets that are delivered within timeframes established by marketplace convention.

Financial instruments are initially measured at fair value plus transactions costs where the instrument is not classified as at fair value through profit or loss. Transaction costs related to instruments classified as at fair value through profit or loss are expensed to profit or loss immediately. Financial instruments are classified and measured as set out below.

Derecognition

Financial assets are derecognised where the contractual rights to receipt of cash flows expires or the asset is transferred to another party whereby the entity is no longer has any significant continuing involvement in the risks and benefits associated with the asset. Financial liabilities are derecognised where the related obligations are either discharged, cancelled or expire. The difference between the carrying value of the financial liability extinguished or transferred to another party and the fair value of consideration paid, including the transfer of non-cash assets or liabilities assumed, is recognised in profit or loss.

Classification and Subsequent Measurement

(i) Financial assets at fair value through profit or loss

Financial assets are classified at fair value through profit or loss when they are held for trading for the purpose of short term profit taking, where they are derivatives not held for hedging purposes, or designated as such to avoid an accounting mismatch or to enable performance evaluation where a group of financial assets is managed by key management personnel on a fair value basis in accordance with a documented risk management or investment strategy. Realised and unrealised gains and losses arising from changes in fair value are included in profit or loss in the period in which they arise.

(ii) Loans and receivables

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market and are subsequently measured at amortised cost using the effective interest rate method.

(iii) Held-to-maturity investments

Held-to-maturity investments are non-derivative financial assets that have fixed maturities and fixed or determinable payments, and it is the group’s intention to hold these investments to maturity. They are subsequently measured at amortised cost using the effective interest rate method.

46 bph energy | 2012 annual report

1. Statement of Significant Accounting Policies (continued)

(e) Financial Instruments (continued)

(iv) Available-for-sale financial assets

Available-for-sale financial assets are non-derivative financial assets that are either designated as such or that are not classified in any of the other categories.

Listed shares held by the Group that are traded in an active market are classified as AFS and are stated at fair value. The Group also has investments in unlisted shares that are not traded in an active market but that are also classified as AFS financial assets and stated at fair value (because the directors consider that fair value can be reliably measured). Gains and losses arising from changes in fair value are recognised in other comprehensive income and accumulated in the investments revaluation reserve, with the exception of impairment losses, interest calculated using the effective interest method, and foreign exchange gains and losses on monetary assets, which are recognised in profit or loss.

(v) Financial Liabilities

Non-derivative financial liabilities are subsequently measured at amortised cost using the effective interest rate method.

Fair value

Fair value is determined based on current bid prices for all quoted investments. Valuation techniques are applied to determine the fair value for all unlisted securities, including recent arm’s length transactions, reference to similar instruments and option pricing models.

Impairment

At each reporting date, the group assesses whether there is objective evidence that a financial instrument has been impaired. In the case of available-for-sale equity financial instruments, a significant or prolonged decline in the value of the instrument below cost is considered to determine whether an impairment has arisen. Impairment losses are recognised in the profit or loss.

(f) Impairment of Assets

At each reporting date, the group reviews the carrying values of its tangible and intangible assets to determine whether there is any indication that those assets have been impaired. If such an indication exists, the recoverable amount of the asset, being the higher of the asset’s fair value less costs to sell and value in use, is compared to the asset’s carrying value. Any excess of the asset’s carrying value over its recoverable amount is expensed to the profit or loss.

(g) Investments in Associates

Associates are all entities over which the group has significant influence but not control or joint control, generally accompanying a shareholding of between 20% and 50% of the voting rights. Investments in associates are accounted for in the parent entity financial statements using the cost method and in the consolidated financial statements using the equity method of accounting, after initially being recognised at cost. The equity method of accounting recognises the group’s share of post-acquisition reserves of its associates.

bph energy | 2012 annual report 47

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(g) Investments in Associates (continued)

The group’s share of its associates’ post-acquisition profits or losses is recognised in the profit or loss, and its share of post-acquisition movements in reserves is recognised in other comprehensive income. The cumulative post-acquisition movements are adjusted against the carrying amount of the investment.

Dividends receivable from associates are recognised in the parent entity’s profit or loss, while in the consolidated financial statements they reduce the carrying amount of the investment.

When the group’s share of losses in an associate equals or exceeds its interest in the associate, including any other unsecured long-term receivables, the group does not recognise further losses, unless it has incurred obligations or made payments on behalf of the associate.

Unrealised gains on transactions between the group and its associates are eliminated to the extent of the group’s interest in the associates. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of associates have been changed where necessary to ensure consistency with the policies adopted by the group.

Where an investment is classified as a financial asset in accordance with AASB 139, at the date significant influence is achieved, the fair value of the investment needs to be assessed. Any fair value gains are recognised in accordance with the treatment the classification the financial asset as required by AASB 139.

Any excess of the cost of acquisition over the Group’s share of the net fair value of the identifiable assets, liabilities and contingent liabilities of the associate recognised at the date of acquisition is recognised as goodwill, which is included within the carrying amount of the investment. Any excess of the Group’s share of the net fair value of the identifiable assets, liabilities and contingent liabilities over the cost of acquisition, after reassessment, is recognised immediately in profit or loss.

(h) Intangibles

Research

Expenditure during the research phase of a project is recognised as an expense when incurred.

Patents and Trademarks

Patents and trademarks are recognised at cost of acquisition. Patents and trademarks have a finite life and are carried at cost less any accumulated amortisation and any impairment losses. Patents and trademarks are amortised over their useful life of 20 years.

(i) Employee Benefits

Provision is made for the company’s liability for employee benefits arising from services rendered by employees to balance date. Short term employee benefits have been measured at the amounts expected to be paid when the liability is settled, plus related on-costs. Long term employee benefits have been measured at the present value of the estimated future cash outflows to be made for those benefits.

(j) Provisions

Provisions are recognised when the group has a legal or constructive obligation, as a result of past events, for which it is probable that an outflow of economic benefits will result and that outflow can be reliably measured.

48 bph energy | 2012 annual report

1. Statement of Significant Accounting Policies (continued)

(k) Cash and Cash Equivalents

Cash and cash equivalents include cash on hand, deposits held at call with banks, other shortterm highly liquid investments, and bank overdrafts. Bank overdrafts are shown within short-term borrowings in current liabilities on the statement of financial position.

(l) Revenue and Other Income

Interest revenue is recognised when it is probable that the economic benefits will flow to the Group and the amount of revenue can be measured reliably. Interest revenue is accrued on a time basis, by reference to the principal outstanding and at the effective interest rate applicable

Dividend revenue is recognised when the right to receive a dividend has been established.

Revenue from the rendering of a service is recognised by reference to the stage of completion of the contract.

All revenue is stated net of the amount of goods and services tax (GST).

(m) Goods and Services Tax (GST)

Revenues, expenses and assets are recognised net of the amount of GST, except where the amount of GST incurred is not recoverable from the Australian Tax Office. In these circumstances the GST is recognised as part of the cost of acquisition of the asset or as part of an item of the expense.

Receivables and payables in the statement of financial position are shown inclusive of GST.

Cash flows are presented in the cash flow statement on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows.

(n) Government Grants

Government grants are recognised at fair value where there is reasonable assurance that the grant will be received and all grant conditions will be met. Grants relating to expense items are recognised as income over the periods necessary to match the grant to the costs they are compensating. Grants relating to assets are credited to deferred income at fair value and are credited to income over the expected useful life of the asset on a straight-line basis.

(o) Trade and other payables

Liabilities are recognized for amounts to be paid in the future for goods or services received, whether or not billed to the consolidated entity. The amounts are unsecured and are usually paid within 30 days.

(p) Share based payments

The fair value of options granted under the Company’s Employee Option Plan is recognized as an employee benefit expense with a corresponding increase in equity. The fair value is measured at grant date and recognized over the period during which the employees become unconditionally entitled to the options.

bph energy | 2012 annual report 49

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(p) Share based payments (continued)

The fair value at grant date is independently determined using a Black and Scholes option pricing model that takes into account the exercise price, the term of the option, the vesting and performance criteria, the impact of dilution, the non-tradeable nature of the option, the share price at grant date and expected volatility of the underlying share, the expected dividend yield and risk free interest rate for the term of the option.

The fair value of the options granted excludes the impact of any non-market vesting conditions (for example, profitability and sales growth targets). Non-market vesting conditions are included in assumptions about the number of options that are expected to vest. At each statement of financial position date, the entity revises its estimate of the number of options that are expected to vest. The employee benefit expense recognised each period takes into account the most recent estimate. Upon the exercise of options, the balance of the share-based payments reserve relating to those options is transferred to share capital.

(q) Earnings per share

Basic earnings per share (EPS) is calculated as net profit/loss attributable to members, adjusted to exclude costs of servicing equity (other than dividends) and preference share dividends, divided by the weighted average number of ordinary shares, adjusted for any bonus element.

Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax effect of interest and other financing costs associated with dilutive potential ordinary shares, and the weighted average number of additional ordinary shares that would have been outstanding assuming the conversion of all dilutive potential ordinary shares.

(r) Critical accounting estimates and judgments

The directors evaluate estimates and judgments incorporated into the financial report based on historical knowledge and best available current information.

Estimates assume a reasonable expectation of future events and are based on current trends and economic data, obtained both externally and within the group.

Key judgements – Provision for Impairment of Loans Receivables

Included in the accounts of Consolidated entity are amounts from current loan receivables of $1,707,203 (2011: $2,720,363) and non-current loan receivable of $289,424 (2011: Nil) . The directors believe that the full amount of the debt will be recoverable from each entity and that no provision for impairment of receivables has been made at 30 June 2012.

Key Judgments – Impairment of Intangible Assets

No impairment has been recognised in respect of intangible assets for the year ended 30 June 2012 (2011: $nil). The directors believe that the carrying value of all intangibles is appropriate after reviewing the status of each entity’s developments. The directors are confident that the products will provide the necessary returns to the Company.

Key Judgments – Fair Value of Financial Assets

The fair value of listed shares has been determined by reference to published price quotations in an active market. The fair values of unlisted securities not traded in an active market are measured at fair value, using recent arms length transactions.

50 bph energy | 2012 annual report

2. Revenue Revenue Interest revenue cash accounts Interest revenue: other entities Total revenue Other income Research & development rebate Consultancy fees Other gains and losses Net gain/loss arising on recognition of derivative 3. Expenses Included in Loss for the year Expenses Depreciation and amortisation - Depreciation - Amortisation - Salary - Superannuation - Director fees - Share based payments - Other payroll costs Total employee costs	Consolidated 2012 $ 2011 $
	100,397 167,248 86,481 184,875
	186,878 352,123
	- 138,525 114,100 114,100
	114,100 252,625
	(131,732) -
	(131,732) -
	789 1,673 - - 177,339 165,927 13,062 12,034 124,992 124,985 8,824 16,710 10,911 (4,521)
	335,128 315,135

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

4. Key Management Personnel Compensation

Names and positions held of economic and parent entity key management personnel in office at any time during the financial year are:

Key Management Personnel

D L Breeze – Executive Chairman

H Goh – Non Executive Director

G Gilbert – Non Executive Director

D Ambrosini – Executive Director and Company Secretary

Short term employee benefits Share based payments	Consolidated 2012 $ 2011 $
	223,000 223,000 - -
	223,000 223,000

Key management personnel remuneration has been included in the Remuneration report section of the Directors Report.

Options and Rights Holdings

2012 Number of Options Held by Key Management Personnel

							Total	Total
		Granted as		Net			Exercisable	Unexercis-
	Balance	Compen-	Options	Change	Balance	Total Vested	and Vested	able
	1.7.2011	sation	Exercised	Other *	30.6.2012	30.6.2012	30.6.2012	30.6.2012
D L Breeze	1,000,000	-	-	-	1,000,000	1,000,000	1,000,000	-
G Gilbert	-	-	-	-	-	-	-	-
H Goh	-	-	-	-	-	-	-	-
D Ambrosini	1,000,000	-	-	-	1,000,000	1,000,000	1,000,000	-

2011 Number of Options Held by Key Management Personnel

							Total	Total
		Granted as		Net			Exercisable	Unexercis-
	Balance	Compen-	Options	Change	Balance	Total Vested	and Vested	able
	1.7.2010	sation	Exercised	Other *	30.6.2011	30.6.2011	30.6.2011	30.6.2011
D L Breeze	2,000,000	-	-	(1,000,000)	1,000,000	1,000,000	1,000,000	-
G Gilbert	2,000,000	-	-	(2,000,000)	-	-	-	-
H Goh	2,000,000	-	-	(2,000,000)	-	-	-	-
D Ambrosini	2,000,000	-	-	(1,000,000)	1,000,000	1,000,000	1,000,000	-

*The Net Change Other reflected above includes those options that have been forfeited by holders, directors that have resigned, options that have expired and recompliance of holdings during the year.

52 bph energy | 2012 annual report

4. Key Management Personnel Compensation (continued) Shareholdings

2012 Number of Shares Held by Key Management Personnel

	Balance	Received as	Options	Net Change	Balance
	1.7.2011	Compensation	Exercised	Other	30.6.2012
D L Breeze	6,509,811	-	-	-	6,509,811
G Gilbert	480,769	-	-	-	480,769
H Goh	480,769	-	-	-	480,769
D Ambrosini	-	-	-	-	-

2011 Number of Shares Held by Key Management Personnel

	Balance	Received as	Options	Net Change	Balance
	1.7.2010	Compensation	Exercised	Other	30.6.2011
D L Breeze	13,019,621	-	-	(6,509,810)	6,509,811
G Gilbert	961,538	-	-	(480,769)	480,769
H Goh	961,538	-	-	(480,769)	480,769
D Ambrosini	-	-	-	-	-

Net Change other relates to share movements directly attributable to the consolidation of BPH capital on a 1:2 basis.

Auditors’ Remuneration Remuneration of the auditor of the parent entity for: - auditing or reviewing the financial report Deloitte Touche Tohmatsu Remuneration of other auditors of subsidiaries for: - auditing or reviewing the financial report of subsidiaries	Consolidated 2012 $ 2011 $
	34,914 34,157 - -
	34,914 34,157

5. Auditors’ Remuneration

bph energy | 2012 annual report 53

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

6. Earnings per share For basic and diluted Earnings Per Share Total earnings per share attributable to ordinary equity holders of the company Earnings used in the calculation of basic earnings per share and diluted earnings per share For basic and diluted Earnings Per Share From continuing operations Total Basic Earnings per Share and Diluted Earnings per Share Weighted average number of ordinary shares outstanding during the year used in calculating basic EPS and diluted EPS 7. Cash and cash equivalents Cash at Bank and in hand Short-term bank deposits Reconciliation of cash Cash at the end of the financial year as shown in the statement of cash flows is reconciled to items in the statement of financial position as follows: Cash and cash equivalents 8. Trade and other receivables Current Other receivables 9. Other Assets Prepaid insurance	Consolidated 2012 $ 2011 $
	(739,165) (220,903)
	(739,165) (220,903)
	(0.41) (0.13)
	(0.41) (0.13)

	No. 181,628,852 No. 170,877,168
	Consolidated 2012 $ 2011 $
	1,791,506 2,915,723 7,418 7,107
	1,798,924 2,922,830

	1,798,924 2,922,830
	2,913 2,857
	2,913 2,857
	18,189 8,778
	18,189 8,778

54 bph energy | 2012 annual report

10. Financial Assets Loans and receivables at amortised cost Current Unsecured Loans to other entities: (a) Grandbridge Limited Cortical Dynamics Limited Molecular Discovery Systems Limited MEC Resources Limited Advent Energy Ltd Secured Loans to other entities: (b) Advent Energy Limited Cortical Dynamics Limited Molecular Discovery Systems Limited Non - Current Loans and receivables at amortised cost Secured loan to Cortical Dynamics (b) Available for sale financial assets at fair value Investments in unlisted entities (c)	Consolidated 2012 $ 2011 $
	55,645 55,645 485,070 100,070 345,200 231,100 2,494 2,494 39,486 41,666 - 1,778,801 478,617 353,238 300,691 157,349
	1,707,203 2,720,363
	289,424 - 48,949 48,949
	338,373 48,949

(a) Unsecured loans

These loans are unsecured, non-interest bearing and repayable on demand.

(b) Secured loans

These loans are secured by a charge over all of the assets and undertakings of each entity and interest bearing. Subject to the conditions of the agreement BPH Energy has the right to conversion to satisfy the debt on or before the termination date.

During the period Advent repaid an amount of $1.8M in full and final settlement of its obligations under the secured loan agreement entered into with BPH Energy on 15 June 2010.

The company has a convertible loan agreement with MDSystems. The loan is for a maximum amount of $500,000 and is to be used for short term working capital requirements. Subject to MDSystems being admitted to the Official list BPH Energy has a right of conversion to satisfy the debt on or before the termination date. As at reporting date the loan been drawn down by an amount of $300,691 (2011: $157,349).

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(b) Secured loans (continued)

The company has entered into a convertible loan agreement with Cortical Dynamics. The loan is for a maximum amount of $500,000 and is to be used for short term working capital requirements. Subject to Cortical being admitted to the Official list BPH Energy has a right of conversion to satisfy the debt on or before the termination date. As at reporting date the loan been drawn down by an amount of $478,617 (2011: $353,238).

On 28th February 2012 BPH Energy entered into a convertible loan agreement with Cortical Dynamics. The facility is for a maximum amount of $1M and has an annual interest rate of 9.40%. The loan will be used for short term working capital requirements and funding further development of the BAR monitor. The facility will terminate on the earlier of 24 months from the execution date and any date on which the facility is terminated in accordance with the agreement. The loan is convertible at BPH’s election if Cortical is unsuccessful in its application for admission to the Official List. As at reporting date the loan had been drawn down by an amount of $289,424 (2011: nil).

(c) Available for sale financial assets at fair value

(c) Available for sale financial assets at fair value
Cortical Dynamics Limited 11. Intangible assets Patent costs capitalised Cost Accumulated amortisation and impairment Net carrying value Total intangibles	Consolidated 2012 $ 2011 $
	48,949 48,949
	48,949 48,949
	72,454 72,454 - -
	72,454 72,454
	72,454 72,454

Patent costs include all costs associated with the filing and maintenance of the patents for the company’s technologies

56 bph energy | 2012 annual report

		Consolidated	Consolidated
		2012	2011
		$	$
12.	Property, Plant and Equipment
	Plant and Equipment:
	At cost	41,486	41,486
	Accumulated depreciation	(40,215)	(39,426)
	Total Property, Plant and Equipment	1,271	2,060
(a)	Movements in Carrying Amounts
	Movements in the carrying amounts for each class of property,
	plant and equipment between the beginning and the end of
	the current financial year.
	Balance at the beginning of the year	2,060	2,190
	Additions	-	1,543
	Disposals	-	-
	Depreciation expense	(789)	(1,673)
	Carrying amount at the end of the year	1,271	2,060
13.	Investments accounted for using the equity method
	Shares in Associates
	Advent Energy Limited	48,819,692	49,052,002
	Molecular Discovery Systems Limited	1,433,792	1,499,519
		50,253,484	50,551,521
(a)	Shares in associates
	Investments in associates are accounted for in the consolidated financial	statements using	the equity
	method of accounting.

		Ownership	Ownership
	Country of	Interest
Name of Entity	Incorporation		%	Principal Activity
		2012	2011
Molecular Discovery Systems Limited	Australia	20%	20%	Biomedical Research
Advent Energy Limited	Australia	27.4%	27.4%	Oil and Gas Exploration

bph energy | 2012 annual report 57

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(a) Summarised financial information of associates

The results of its associates aggregated assets (including goodwill) and liabilities, including the group’s share of net assets and net loss for the period are as follows:

Total of Associate Groups Share of:	Total of Associate Groups Share of:
Ownership interest % Assets Liabilities Profits/ Losses Revenues Net Assets Net Loss for the Period
2012 Molecular Discovery Systems Limited 20 Advent Energy Ltd 27.4 2011 Molecular Discovery Systems Ltd 20 Advent Energy Ltd 27.4	768,728 937,948 (328,635) 120,042 (33,844) (65,727)
	768,728 937,948 (328,635) 120,042 (33,844) (65,727)
	35,131,919 6,756,044 (847,848) 521,565 7,774,990 (232,310)
	35,131,919 6,756,044 (847,848) 521,565 7,774,990 (232,310)
	757,495 604,405 (346,356) 89,683 30,618 (69,270)
	757,495 604,405 (346,356) 89,683 30,618 (69,270)
	38,939,408 9,709,478 (7,095,097) 403,809 8,017,770 (1,097,998)
	38,939,408 9,709,478 (7,095,097) 403,809 8,017,770 (1,097,998)

14. Income Tax Expense (a) The components of tax expense comprise: Current tax Deferred tax	Consolidated 2012 $ 2011 $
	- - (277,893) (1,825,599)
	(277,893) (1,825,599)

58 bph energy | 2012 annual report

14. Income Tax Expense (continued) (b) The prima facie tax on profit from operations before income tax is reconciled to the income tax as follows: Prima facie tax payable on profit from operations before income tax at 30% (2011: 30%) Add tax effect of: Non deductible expenses Effect of concessions (research and development) Tax benefit of revenue losses not recognised Effect of previously unrecognised and unused tax losses now recognised as deferred tax assets Temporary differences Income tax expense/(benefit) recognised Weighted average rate of tax (c) Income tax expense recognised in other comprehensive income Fair value gain adjustments (d) Current tax liabilities Income tax 15. Trade and other payables Trade payables Sundry payables and accrued expenses 16. Financial Liabilities Current Current borrowings – unsecured	Consolidated 2012 $ 2011 $
	(312,711) (628,044) 7,924 25,319 - - - - - (1,222,874) 26,894 -
	(277,893) (1,825,599)
	(21%) (87%) - 6,435,000
	6,435,000
	- -
	- -
	29,212 14,898 543,368 367,581
	572,580 382,479
	479,502 434,853
	479,502 434,853

Current borrowings are unsecured, non interest bearing and repayable on demand.

bph energy | 2012 annual report 59

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

17. Provisions Short term employee entitlements: Opening balance at 1 July 2011 Reduction/addition to provision Balance at 30 June 2012 Provision for Employee Entitlements Provisions have been recognised for employee entitlements relating to annual leave. The measurement and recognition criteria relating to employee benefits has been included in Note 1 to this report.	Consolidated 2012 $ 2011 $
	9,161 12,438 10,911 (3,277)
	20,072 9,161

18. Issued Capital 172,562,245 (2011: 216,106,207) fully paid ordinary shares The Company has no authorised capital and the issued shares do not have a par value. Consolidated 2012 $ 2011 $ (a) Ordinary Shares At the beginning of reporting period 42,860,310 22,427,420 Shares issued – entitlement issue/ shareholder share placement - 8,237,502 Conversion of quoted options 885 - Shares issued – purchase of 3M shares in Advent Energy - 1,500,000 Consolidation of capital 1:2 basis - - Shares issued through recompliance prospectus - 11,514,920 Payment for consultancy services - 68,338 Shares cancelled – Selective buyback (1,350,000) - Capital Raising costs - (887,870) At reporting date 41,511,195 42,860,310	18. Issued Capital 172,562,245 (2011: 216,106,207) fully paid ordinary shares The Company has no authorised capital and the issued shares do not have a par value. Consolidated 2012 $ 2011 $ (a) Ordinary Shares At the beginning of reporting period 42,860,310 22,427,420 Shares issued – entitlement issue/ shareholder share placement - 8,237,502 Conversion of quoted options 885 - Shares issued – purchase of 3M shares in Advent Energy - 1,500,000 Consolidation of capital 1:2 basis - - Shares issued through recompliance prospectus - 11,514,920 Payment for consultancy services - 68,338 Shares cancelled – Selective buyback (1,350,000) - Capital Raising costs - (887,870) At reporting date 41,511,195 42,860,310	41,511,195 42,860,310
		Consolidated 2012 No. 2011 No.
	42,860,310 22,427,420 - 8,237,502 885 - - 1,500,000 - - - 11,514,920 - 68,338 (1,350,000) - - (887,870)	216,106,207 206,954,246 - 103,314,033 4,425 - - 18,750,000 - (164,717,502) - 50,951,205 - 854,225 (43,548,387) - - -
	41,511,195 42,860,310	172,562,245 216,106,207

60 bph energy | 2012 annual report

18. Issued Capital (continued)

Capital Raising

There were 4,425 options exercised during the year (2011: nil).

Fully Paid Ordinary Share Capital

Fully paid ordinary shares carry one vote per share and carry the right to dividends.

Options

There were 4,075,000 employee options on issue at the end of the year:

Total number	Exercise price	Expiry date
250,000	*	29 April 2013
1,125,000	$0.294	30 June 2013
500,000	$0.294	16 December 2013
75,000	$0.594	30 September 2014
1,500,000	$0.894	31 December 2014
625,000	$0.160	21 January 2016
4,075,000

The exercise price will be the average amount determined by the market price for the 5 days prior to exercise.

The market price of the company’s ordinary shares at 30 June 2012 was 1.7 cents.

The holders of options do not have the right, by virtue of the option, to participate in any share issue or interest issue of any other body corporate or registered scheme.

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(b) Capital risk management

The Group’s and the parent entity’s objectives when managing capital are to safeguard their ability to continue as a going concern, so that they may continue to provide returns for shareholders and benefits for other stakeholders.

The focus of the Group’s capital risk management is the current working capital position against the requirements of the Group to meet corporate overheads. The Group’s strategy is to ensure appropriate liquidity is maintained to meet anticipated operating requirements, with a view to initiating appropriate capital raisings as required. The working capital position of the Group at 30 June 2012 and 30 June 2011 are as follows:

Cash and cash equivalents Trade and other receivables Trade and other payables Working capital position 19. Reserves Options Reserve (a) Asset Revaluation Reserve (b) a. Option Reserve The option reserve records items recognized as expenses on the valuation of Director and Employee share options. Reconciliation of movement Opening balance Option charges during the year Closing balance b. Asset Revaluation Reserve The asset revaluation reserve records the revaluation of available for sale investments to fair value. Reconciliation of movement Opening balance Available for sale asset revalued to fair value (net of tax) Closing balance	Consolidated 2012 $ 2011 $
	1,798,924 2,922,830 2,913 2,857 (572,580) (382,479)
	1,229,257 2,543,208
	416,590 407,766 15,015,000 15,015,000
	15,431,590 15,422,766
	407,766 391,056 8,824 16,710
	416,590 407,766
	15,015,000 - - 15,015,000
	15,015,000 15,015,000

62 bph energy | 2012 annual report

20. Controlled Entities

20. Controlled Entities
Name of Entity Principal Activity Country of Incorporation	Ownership Interest %
Parent Entity BPH Energy Limited Subsidiaries of BPH Energy Limited Diagnostic Array Systems Pty Limited Investment BioMedical Research Australia Australia	2012 2011 51.82 51.82
21. Cash Flow Information (a) Reconciliation of Cash Flow from Operations with Profit after income tax Operating loss after income tax Non-cash flows in profit: Depreciation and amortisation Interest Revenue Share based payment expense Intercompany recharges Share of Associates Loss Changes in net assets and liabilities, net of effects of purchase and disposal of subsidiaries (Increase)/decrease in trade and other receivables Increase)/decrease in other assets Increase/(decrease) in provisions Increase/(decrease) in trade payables and accruals Increase/(decrease) in deferred tax liabilities Cash outflow from operations Nil (2011: 854,224) shares were issued for consultancy services (c) Financing Facilities Credit card facility (limit) Used credit card facility	Consolidated 2012 $ 2011 $
	(764,478) (267,884) 789 1,673 (64,393) 184,875 8,824 16,710 109,809 (129,624) 298,037 1,167,268 (56) 78,834 (9,412) 7,167 10,911 (4,521) 190,123 (181,800) (277,893) (1,825,599)
	(497,739) (1,322,651) - 68,338 20,000 20,000 - -

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

22. Financial Risk Management

(a) Financial Risk Management

The group’s financial instruments consist mainly of deposits with banks, short-term investments, accounts receivable and payable, and loans to and from subsidiaries. The main purpose of nonderivative financial instruments is to raise finance for group operations policies.

i. Financial Risk Exposures and Management

The main risks the group is exposed to through its financial instruments are interest rate risk, liquidity risk, credit risk and equity price risk.

Interest rate risk

Interest rate risk is managed with a mixture of fixed and floating rate debt.

Liquidity risk

The Group manages liquidity risk by maintaining adequate reserves, by continuously monitoring forecast and actual cash flows.

Credit risk

The maximum exposure to credit risk, excluding the value of any collateral or other security, at balance date to recognised financial assets, is the carrying amount, net of any provisions for impairment of those assets, as disclosed in the statement of financial position and notes to the financial statements.

Credit risk for derivative financial instruments arises from the potential failure by counter-parties to the contract to meet their obligations.

The economic entity does not have any material credit risk exposure to any single receivable or group of receivables under financial instruments entered into by the economic entity.

Equity price risk

The Group is exposed to equity price risks arising from equity investments. Equity investments are held for strategic rather than trading purposes. The Group does not actively trade these investments.

Foreign currency risk

The Group is not exposed to any material risks in relation to fluctuations in foreign exchange rates.

64 bph energy | 2012 annual report

22. Financial Risk Management (continued)

(b) Financial Instruments

i. Interest rate risk

The economic entity’s exposure to interest rate risk, which is the risk that a financial instrument’s value will fluctuate as a result of changes in market interest rates and the effective weighted average interest rates on classes of financial assets and financial liabilities, is as follows:

Consolidated Group

Consolidated Group
2012 Weight Effective Interest Rate %	Floating Interest Rate $ Fixed Interest Rate 1 Year of less Fixed Interest Rate 1 to 5 Years Non-Interest Bearing $ Total $
Financial Assets Cash and cash equivalents 3.38 Trade and other receivables Other financial assets 8.41 Total Financial Assets Financial Liabilities Trade and sundry payables Financial liabilities Total Financial Liabilities	1,798,924 - - - 1,798,924 - - - 2,913 2,913 - 779,308 289,424 927,895 1,996,627
	1,798,924 779,308 289,424 930,808 3,798,464
	- - - 572,580 572,580 - - - 479,502 479,502
	- - - 1,052,082 1,052,082

2011 Weight Effective Interest Rate %	Floating Interest Rate $ Fixed Interest Rate 1 Year of less Fixed Interest Rate 1 to 5 Years Non-Interest Bearing $ Total $
Financial Assets Cash and cash equivalents 4.50 Trade and other receivables Other financial assets 7.93 Total Financial Assets Financial Liabilities Trade and sundry payables Financial liabilities Total Financial Liabilities	2,922,830 - - - 2,922,830 - - - 2,857 2,857 - 2,331,054 - 389,309 2,720,363
	2,922,830 2,331,054 - 392,166 5,646,050
	- - - 382,479 382,479 - - - 434,853 434,853
	- - - 817,332 817,332

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

(b) Financial Instruments (continued)

ii. Fair Values

The fair values of:

Term receivables are determined by discounting the cash flows, at the market interest rates of similar securities, to their present value.
Other loans and amounts due are determined by discounting the cash flows, at market interest rates of similar borrowings to their present value.
For unlisted investments where there is no organised financial market, the fair value has been based on a reasonable estimation of the underlying net assets or discounted cash flows of the investment.
Other assets and liabilities approximate their carrying value.

No financial assets and financial liabilities are readily traded on organised markets in standardised form other than listed investments.

Financial Assets Available-for-sale financial assets Loans and receivables Financial Liabilities Other loans and amounts due Trade payables	2012 2011 Carrying Amount Fair Value Carrying Amount Fair Value
	48,949 48,949 48,949 48,949 1,999,540 1,999,540 2,723,220 2,723,220
	2,048,489 2,048,489 2,772,169 2,772,169
	479,502 479,502 434,853 434,853 572,580 572,580 382,479 382,479
	817,332 817,332 817,332 817,332

Reconciliation of fair value measurements of financial assets in Level 3 Hierarchy:

Opening balance Less: reclassifications Closing balance	2012 Available for sale 2011 Available for sale
	48,949 12,848,949 - (12,800,000)
	48,949 48,949

The reclassification during the prior year relates to the investment in Advent Energy Ltd. Advent Energy Ltd is now accounted for as an associate.

66 bph energy | 2012 annual report

22. Financial Risk Management (continued)

(b) Financial Instruments (continued)

iii. Sensitivity Analysis

Interest Rate Risk

The group has performed sensitivity analysis relating to its exposure to interest rate risk at balance date. This sensitivity analysis demonstrates the effect on the current year results and equity which could result from a change in these risks.

Interest Rate Sensitivity Analysis

The effect on profit and equity as a result of changes in the interest rate, with all other variables remaining constant would be as follows:

remaining constant would be as follows:
Change in profit — Increase in interest rate 1% — Decrease in interest rate by 0.5%	Consolidated Group 2012 2011
	31,978 25,942 (15,989) (12,971)

Liquidity Risk Management

The Group manages liquidity risk by maintaining adequate reserves, banking facilities and reserve borrowing facilities, by continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.

23. Operating Segment

Operating segments have been identified on the basis of internal reports of the Company that are regularly reviewed by the chief operating decision maker in order to allocate resources to the segments and to assess their performance. The chief operating decision maker has been identified as the Board of Directors. On a regular basis, the board receives financial information on the consolidated entity on a basis similar to the financial statements presented in the financial report, to manage and allocate their resources.

The consolidated entity holds investments in two principal industries and these are biotechnology, and oil and gas exploration and development, as disclosed in Note 10 (c) and Note 13.

24. Events after the Statement of financial position Date

bph energy | 2012 annual report

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

25. Related Party Transactions

(a) Equity interests in controlled entities

Details of the percentage of ordinary shares held in controlled entities are disclosed in note 20 to the financial statements.

(b) Directors’ Remuneration

Details of the directors’ remuneration and retirement benefits is located in the Directors Report and in note 4.

(c) Directors’ Equity Holdings

Directors’ Equity Holdings
Ordinary Shares Held as at the date of this report by directors and their director-related entities in: BPH Energy Limited Other Equity Instruments Options Held as at the date of this report by directors and their director-related entities in: BPH Energy Limited	Parent 2012 2011 No. No.
	7,471,349 7,471,349 2,000,000 2,000,000

(d) Directors

The Company has an agreement with Trandcorp Pty Limited on normal commercial terms procuring the services of David Breeze to provide product development services. $98,000 (2011: $98,000) was paid during the year.

(e) Interest in Associates

A loan receivable exists between BPH Energy and MDSystems $345,200 (2011:$231,100). This amount is unsecured, non interest bearing and repayable on demand.

A loan payable exists between BPH Energy and MDSystems $61,310 (2011:$61,310). This amount is unsecured, non interest bearing and repayable on demand

A convertible loan agreement exists between BPH Energy and MDSystems. The loan is for a maximum amount of $500,000 and is to be used for short term working capital requirements. Subject MDSystems being admitted to the Official list BPH Energy has a right of conversion to satisfy the debt on or before the termination date. As at reporting date the loan been drawn down by an amount of $300,691 (2011: $157,349). Interest charged on the loan totalled $20,293 (2011: $2,348).

68 bph energy | 2012 annual report

25. Related Party Transactions (continued)

(e) Interest in Associates (continued)

During the year, BPH Energy provided consultancy services to MDSystems of $114,100 (2011: $114,100).

A convertible loan agreement existed between BPH Energy and Advent Energy Ltd $nil (2011:$ 1,778,801) On 19th August 2011 Advent repaid the loan in full. Interest charged on the loan totalled $22,088 (2011: $178,801).

Further, a loan payable exists between Advent to BPH of $ 39,486 (2011:$ 41,666). This amount is unsecured, non interest bearing and repayable on demand.

(f) Other

The Company entered into a selective buyback agreement with MEC Resources Limited. BPH Energy agreed to buy back up to $1.35 million of MEC’s shareholding in the Company. The number of buyback Shares was determined by dividing the total Consideration by the 5-day volume weighted average closing price of Shares prior to the date of the buy-back;

26. Share-Based Payments

The following share-based payment arrangements existed at 30 June 2012:

Total number	Grant Date	Exercise price	Fair value at	Expiry date
			grant date
250,000	29 April 2008	*	$0.0225	29 April 2013
1,125,000	1 June 2008	$0.294	$0.0232	30 June 2013
500,000	16 December 2008	$0.294	$0.0119	16 December 2013
75,000	25 September 2009	$0.594	$0.0423	30 September 2014
1,500,000	24 December 2009	$0.894	$0.0266	31 December 2014
625,000	21 January 2011	$0.160	$0.0220	21 January 2016
4,075,000

*The exercise price will be the average amount determined by the market price for the 5 days prior to exercise.

At balance date, no share option has been exercised (2011: nil).

All options granted to key management personnel are to purchase ordinary shares in BPH Energy Limited, which confer a right of one ordinary share for every option held.

bph energy | 2012 annual report 69

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

26. Share-Based Payments (continued)

Outstanding at the beginning of the year Granted Forfeited Expired Expired Outstanding at year-end Exercisable at year-end	Consolidated Group 2012 2011
	Number of Options Weighted Average Exercise Price $ Number of Options Weighted Average Exercise Price $
	4,325,000 0.25 13,700,000 0.22 - - 655,000 0.16 - - (4,000,000) - (250,000) - (30,000) 0.16 - - (6,000,000) 0.294
	4,075,000 0.25 4,325,000 0.25
	3,633,333 0.25 3,483,333 0.25

No options were exercised during the year ended 30th June 2012 (2011:nil).

Included under employee benefits expense in the profit and loss is $8,824 (2011: $16,710), and relates, in full, to equity.

27. Commitments and Contingencies

At reporting date there are no contingent liabilities.

The company has entered into a convertible loan agreement with Cortical Dynamics. The loan is for a maximum amount of $500,000 and is to be used for short term working capital requirements. Subject Cortical being admitted to the Official list BPH Energy has a right of conversion to satisfy the debt on or before the termination date. As at reporting date the loan been drawn down by an amount of $478,617 (2011: $353,238).

During the year BPH Energy entered into a convertible loan agreement with Cortical Dynamics. The loan is for a maximum amount of $1,000,000 and is to be used for short term working capital requirements and further development of the BAR Monitor. The loan is convertible at BPH’s election if Cortical is unsuccessful in its application for admission to the Official List. As at reporting date the loan had been drawn down by an amount of $289,424 (2011: nil).

70 bph energy | 2012 annual report

28. Parent Entity Disclosures Financial Position Assets Current assets Non-current assets Total asset Liabilities Current liabilities Non-current liabilities Total liabilities Equity Issued Capital Retained earnings Reserves Option Reserve Asset Revaluation Reserve Total equity Financial Performance Profit/Loss for the year Other comprehensive income Total comprehensive income	Parent 2012 2011
	4,450,402 6,482,587 50,593,128 51,456,012
	55,043,530 57,938,599
	872,278 585,178 4,369,581 4,609,401
	5,241,859 5,194,579
	41,511,195 42,860,310 (7,141,114) (5,539,056) 416,590 407,766
	15,015,000 15,015,000
	49,801,671 52,744,020
	(1,602,058) (159,700) - 15,015,000
	(1,602,058) 14,855,300

bph energy | 2012 annual report 71

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

29. Tax (a) Liabilities Current Income tax Non Current Deferred tax liabilities comprises: Fair value gain adjustments (b) Assets Deferred tax assets comprise: Prepayments Provisions Accrued expenses Tax losses (c) Deferred tax balances are presented in the statement of financial position as follows: Deferred tax assets Deferred tax liabilities Closing balance	Parent 2012 2011
	- -
	6,466,039 6,555,456
	6,466,039 6,555,456
	5,456 2,633 6,022 2,748 159,688 65,507 1,963,365 1,875,167
	2,134,531 1,946,055
	2,134,531 1,946,055 (6,466,039) (6,555,456)
	(4,331,508) (4,609,401)

30. Application of New and Revised Accounting Standards

(a) Standards and Interpretations adopted in the current year

The Company has adopted all of the new and revised Standards and Interpretations issued by the Australian Accounting Standards Board that are relevant to their operations and are effective for the current financial reporting period beginning 1 July 2011.

The following new and revised Standards and Interpretations have been adopted in the current period:

AASB 124 ‘Related Party Disclosures’ (revised December 2009) and AASB 2009-12 ‘Amendments to Australian Accounting Standards’
AASB 2010-4 ‘Further Amendments to Australian Accounting Standards arising from the Annual Improvements Project’
AASB 2010-5 ‘Amendments to Australian Accounting Standards’
AASB 2010-6 ‘Amendments to Australian Accounting Standards – Disclosures on Transfers of Financial Assets’

The impact of the adoption of these Standards and Interpretation did not have a material impact on the Company.

72 bph energy | 2012 annual report

30. Application of New and Revised Accounting Standards (continued)

(b) Standards and Interpretations in issue not yet adopted

At the date of authorisation of the financial statements, following Australian Accounting Standards and Interpretations have recently been issued or amended but are not yet effective and have not been adopted by the Company for the year ended 30 June 2012:

==> picture [442 x 56] intentionally omitted <==

----- Start of picture text -----

Standard / Interpretation Effective for annual Expected to be initially
reporting periods applied in the financial
beginning on year ending
or after
----- End of picture text -----

Standard / Interpretation	Effective for annual reporting periods beginning on or after	Expected to be initially applied in the financial year ending

AASB 9 ‘Financial Instruments’ (December 2009), AASB 2009- 11 ‘Amendments to Australian Accounting Standards arising from AASB 9’ AASB 9 ‘Financial Instruments’ (December 2010) and AASB 2010-7 ‘Amendments to Australian Accounting Standards arising from AASB 9 (December 2010)’	1 January 2013	30 June 2014
AASB 10 ‘Consolidated Financial Statements’	1 January2013	30 June 2014
AASB 11 ‘Joint Arrangements’	1 January2013	30 June 2014
AASB 12 ‘Disclosure of Interests in Other Entities’	1 January2013	30 June 2014
AASB 127 ‘Separate Financial Statements’(2011)	1 January2013	30 June 2014
AASB 128 ‘Investments in Associates and Joint Ventures’(2011)	1 January 2013	30 June 2014
AASB 13 ‘Fair Value Measurement’ and AASB 2011-8 ‘Amendments to Australian Accounting Standards arisingfrom AASB 13’	1 January 2013	30 June 2014
AASB 119 ‘Employee Benefits’ (2011) and AASB 2011-10 ‘Amendments to Australian Accounting Standards arisingfrom AASB 119(2011)’	1 January 2013	30 June 2014
AASB 2010-8 ‘Amendments to Australian Accounting Standards – Deferred Tax: Recovery of UnderlyingAssets’	1 January 2012	30 June 2013
AASB 2011-4 ‘Amendments to Australian Accounting Standards to Remove Individual Key Management Personnel Disclosure Requirements’	1 July 2013	30 June 2014
AASB 2011-7 ‘Amendments to Australian Accounting Standards arising from the Consolidation and Joint Arrangements Standards’	1 January 2013	30 June 2014
AASB 2011-9 ‘Amendments to Australian Accounting Standards – Presentation of Items of Other Comprehensive Income’	1 July 2012	30 June 2013

bph energy | 2012 annual report 73

health[n] technology[n] resources

Notes to the Financial Statements

for the year ended 30 June 2012

==> picture [441 x 56] intentionally omitted <==

Standard / Interpretation	Effective for annual reporting periods beginning on or after	Expected to be initially applied in the financial year ending

AASB 2012-2 ‘Amendments to Australian Accounting Standards – Disclosures – Offsetting Financial Assets and Financial Liabilities (Amendments to AASB 7)’	1 January 2013	30 June 2014
AASB 2012-3 ‘Amendments to Australian Accounting Standards – Offsetting Financial Assets and Financial Liabilities (Amendments to AASB 132)’	1 January 2014	30 June 2015
AASB 2012-5 Amendments to Australian Accounting Standards arising from Annual Improvements 2009–2011 Cycle	1 January 2013	30 June 2014

At the date of authorisation of the financial statements the following IASB Standards and IFRIC Interpretations were also in issue but not yet effective, although Australian equivalent Standards and interpretations have not yet been issued and have not been adopted by the Company for the year ended 30 June 2012.

Standard / Interpretation	Effective for annual reporting periods beginning on or after	Expected to be initially applied in the financial year ending
Mandatory Effective Date of IFRS 9 and Transition Disclosures(Amendments to IFRS 9 and IFRS 7)	1 January 2015	30 June 2016
Consolidated Financial Statements, Joint Arrangements and Disclosure of Interests in Other Entities: Transition Guidance (Amendments to IFRS 10, IFRS 11 and IFRS 12)	1 January 2013	30 June 2014

The impact of these recently issued or amended standards and interpretations have not been determined as yet by the Company.

74 bph energy | 2012 annual report

Directors’ Declaration

The directors of the company declare that:

the financial statements and notes, as set out on pages 38 to 74 are in accordance with the Corporations Act 2001 and:
(a) comply with Accounting Standards and the Corporations Regulations 2001 and other mandatory professional reporting requirements;
(b) give a true and fair view of the financial position as at 30 June 2012 and of the performance for the year ended on that date of the consolidated entity;
in the Directors’ opinion, there are reasonable grounds to believe that the company will be able to pay its debts as and when they become due and payable:
the financial statements and notes comply with International Financial Reporting Standards as disclosed in Note 1.
the directors have been given the declarations required by S295A of the Corporations Act 2001 .

Signed in accordance with a resolution of the directors made pursuant to S295(5) of the Corporations Act 2001 .

==> picture [127 x 53] intentionally omitted <==

David Breeze Executive Chairman

Dated this 30th day of August 2012

bph energy | 2012 annual report 75

health[n] technology[n] resources

Independent Auditor’s Report

==> picture [113 x 21] intentionally omitted <==

Independent Auditor’s Report to the members of BPH Energy Limited

Report on the Financial Report

We have audited the accompanying financial report of BPH Energy Limited, which comprises the statement of financial position as at 30 June 2012, the statement of comprehensive income, the statement of cash flows and the statement of changes in equity for the year ended on that date, notes comprising a summary of significant accounting policies and other explanatory information, and the directors’ declaration of the consolidated entity, comprising the company and the entities it controlled at the year’s end or from time to time during the financial year as set out on pages 38 to 75.

Directors’ Responsibility for the Financial Report

The directors of the company are responsible for the preparation of the financial report that gives a true and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the directors determine is necessary to enable the preparation of the financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error. In Note 1, the directors also state, in accordance with Accounting Standard AASB 101 Presentation of Financial Statements , that the consolidated financial statements comply with International Financial Reporting Standards.

Auditor’s Responsibility

Our responsibility is to express an opinion on the financial report based on our audit. We conducted our audit in accordance with Australian Auditing Standards. Those standards require that we comply with relevant ethical requirements relating to audit engagements and plan and perform the audit to obtain reasonable assurance whether the financial report is free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial report. The procedures selected depend on the auditor’s judgement, including the assessment of the risks of material misstatement of the financial report, whether due to fraud or error. In making those risk assessments, the auditor considers internal control, relevant to the company’s preparation of the financial report that gives a true and fair view, in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the directors, as well as evaluating the overall presentation of the financial report.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Auditor’s Independence Declaration

In conducting our audit, we have complied with the independence requirements of the Corporations Act 2001 . We confirm that the independence declaration required by the Corporations Act 2001 , which has been given to the directors of BPH Energy Limited, would be in the same terms if given to the directors as at the time of this auditor’s report.

Liability limited by a scheme approved under Professional Standards Legislation. Member of Deloitte Touche Tohmatsu

76 bph energy | 2012 annual report

Opinion

In our opinion:

(a) the financial report of BPH Energy Limited is in accordance with the Corporations Act 2001 , including:
(i) giving a true and fair view of the consolidated entity’s financial position as at 30 June 2012 and of its performance for the year ended on that date; and
(ii) complying with Australian Accounting Standards and the Corporations Regulations 2001 ; and
(b) the consolidated financial statements also comply with International Financial Reporting Standards as disclosed in Note 1.

Report on the Remuneration Report

We have audited the Remuneration Report included in pages 23 to 26 of the directors’ report for the year ended 30 June 2012. The directors of the company are responsible for the preparation and presentation of the Remuneration Report in accordance with section 300A of the Corporations Act 2001 . Our responsibility is to express an opinion on the Remuneration Report, based on our audit conducted in accordance with Australian Auditing Standards.

Opinion

In our opinion the Remuneration Report of BPH Energy Limited for the year ended 30 June 2012, complies with section 300A of the Corporations Act 2001 .

DELOITTE TOUCHE TOHMATSU

Chris Nicoloff Partner Chartered Accountants

Perth, 30 August 2012

bph energy | 2012 annual report 77

health[n] technology[n] resources

Additional Securities Exchange Information

Additional information required by Australian Securities Exchange Limited and not shown elsewhere in this report as follows.

The information is made up to 13th August 2012

1. Substantial Shareholder

The name of the substantial shareholder listed in the company’s register is:

==> picture [413 x 33] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Shareholder|Shares|%|
|MEC Resources Ltd|14,366,095|8.33|

----- End of picture text -----

2. (a) Distribution of Shareholders

==> picture [412 x 33] intentionally omitted <==

----- Start of picture text -----

Range of Holding Shareholders Number Ordinary %
Shares
----- End of picture text -----

==> picture [412 x 102] intentionally omitted <==

----- Start of picture text -----

|||||
|---|---|---|---|
|1 – 1,000|445|187,506|0.11|
|1,001 – 5,000|557|1,860,033|1.08|
|5,001 – 10,000|450|3,498,695|2.03|
|10,001 – 100,000|1,204|43,744,502|25.35|
|100,001 and over|291|123,271,509|71.44|
|2,947|172,562,245|100.00|

----- End of picture text -----

The number of shareholders with less than a marketable parcel is 2,157, holding in total 19,144,864 shares.

(b) Distribution of Listed Optionholders

==> picture [412 x 81] intentionally omitted <==

----- Start of picture text -----

|||||
|---|---|---|---|
|Range of Holding|Shareholders|Number Ordinary|%|
|Shares|
|10,001 – 100,000|4|275,000|0.07|
|100,001 and over|6|3,800,000|99.93|
|10|4,075,000|100.00|

----- End of picture text -----

3. Voting Rights - Shares

All ordinary shares issued by BPH Energy Limited carry one vote per share without restriction.

4. Voting Rights - Options

All ordinary shares issued by BPH Energy Limited carry one vote per share without restriction.

78 bph energy | 2012 annual report

5. Restricted Securities

The Company does not have any restricted securities.

Number of Shares free of escrow 172,562,245

6. Twenty Largest Shareholders as at 13 August 2012

The names of the twenty largest shareholders of the ordinary shares of the company are:

==> picture [412 x 34] intentionally omitted <==

----- Start of picture text -----

Name Number of ordinary % held of issued
fully paid shares ordinary capital
----- End of picture text -----

Name	Number of ordinary fully paid shares % held of issued ordinary capital
MEC Resources Ltd Trandcorp Pty Ltd JP Morgan Nom Aust Ltd Grandbridge Limited Claymore Capital PL Avatar Equities PL Syracuse Cap PL Trandcorp Pty Ltd Kizogo PL Tre PL McCreed Simon Charles Yewfong Co Pl Batras One PL Hutchfield Robert A Negus Dental Services PL Nefco Nom PL Lewis Gary Leon and S A Gallin Nicole and Hanes K Jones Shane Robert and C R Knight Kenneth I	14,366,095 4,772,500 3,700,000 3,649,371 3,389,100 2,459,049 2,192,223 2,070,689 1,800,000 1,764,303 1,591,926 1,549,872 1,460,000 1,455,254 1,389,000 1,387,401 1,300,000 1,250,000 1,122,500 1,100,000 8.33 2.77 2.14 2.11 1.96 1.43 1.27 1.20 1.04 1.02 0.92 0.90 0.85 0.84 0.80 0.80 0.75 0.72 0.65 0.64
	53,769,283 31.14

bph energy | 2012 annual report

health[n] technology[n] resources

This page has been left blank intentionally.

80 bph energy | 2012 annual report

ACN 095 912 002

14 View Street, North Perth Western Australia 6006 Telephone: (08) 9328 8366 Facsimile: (08) 9328 8733 Email: [email protected]

www.bphenergy.com.au

==> picture [157 x 109] intentionally omitted <==

health[n] resources technology[n]

AI assistant

BPH ENERGY LTD — Annual Report 2012

64555_rns_2012-10-04_cdd96033-9f62-4d08-a5ca-d4d42738f0ee.pdf

Contents

health[n] resources technology[n]

Company Information

Directors

Scientific Advisors

Registered Office

Principal Business Address

Auditor

Share Registry

Australian Business Number

Chairman’s Letter

Company Focus and Developments

Molecular Discovery Systems

Novel Anti-Microtubule Cancer Therapeutics

Drug Discovery and High-Content Screening Technology

Company Focus and Developments

HLS5 Technology

Cortical Dynamics

BAR Technology

Company Focus and Developments

Diagnostic Array Systems

Company Focus and Developments

Advent Energy

Western Australia / Northern Territory – Onshore Bonaparte Basin

Company Focus and Developments

Unconventional Resources Within EP 386 and RL 1

Initial study of shale gas potential in EP 386 and RL 1

Company Focus and Developments

Garimala-1: Elevated Gas Shows over Milligans-Langfield Section

PEP 11 Oil and Gas Permit

Company Focus and Developments

Western Australia – Exmouth Sub-Basin (EP325)

Directors’ Report

Directors

Company Secretary

Principal Activities

Operating Results

Dividends

Review of Operations

Investment in Oil and Gas Exploration Company

Advent Energy Ltd (“Advent”):

Directors’ Report

Investment in Biotechnology Companies

Molecular Discovery Systems Limited (‘MDSystems’)

HLS5 Project:

Cortical Dynamics Limited (‘Cortical Dynamics’):

Diagnostic Array Systems (“DAS”)

Financial Position

Directors’ Report

Significant Changes in State Of Affairs

After Balance Date Events

Environmental Issues

Future Developments

Information on Directors

D L Breeze

G Gilbert

Directors’ Report

H Goh

D Ambrosini

Remuneration Report (Audited)

Remuneration Policy

Directors’ Report

Employment contracts of key management personnel

Details of Remuneration for the year ended 30 June 2012

2012

Directors’ Report

Company performance, shareholder wealth and director and executive remuneration

Share based payments:

Additional Information

Meetings of Directors

Indemnifying Officers or Auditors

Non-audit Services

Directors’ Report

Options

Unlisted Options

Proceedings on Behalf of Company

Auditor’s Independence Declaration

BPH ENERGY LTD Annual Report 2012